<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65420</article-id><article-id pub-id-type="doi">10.7554/eLife.65420</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Evolutionary Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>A common 1.6 mb Y-chromosomal inversion predisposes to subsequent deletions and severe spermatogenic failure in humans</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-217225"><name><surname>Hallast</surname><given-names>Pille</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0588-3987</contrib-id><email>pille.hallast@ut.ee</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217517"><name><surname>Kibena</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217518"><name><surname>Punab</surname><given-names>Margus</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217519"><name><surname>Arciero</surname><given-names>Elena</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217520"><name><surname>Rootsi</surname><given-names>Siiri</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217521"><name><surname>Grigorova</surname><given-names>Marina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217522"><name><surname>Flores</surname><given-names>Rodrigo</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217523"><name><surname>Jobling</surname><given-names>Mark A</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217524"><name><surname>Poolamets</surname><given-names>Olev</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217525"><name><surname>Pomm</surname><given-names>Kristjan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217526"><name><surname>Korrovits</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217527"><name><surname>Rull</surname><given-names>Kristiina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217528"><name><surname>Xue</surname><given-names>Yali</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-50680"><name><surname>Tyler-Smith</surname><given-names>Chris</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-18163"><name><surname>Laan</surname><given-names>Maris</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8519-243X</contrib-id><email>maris.laan@ut.ee</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Institute of Biomedicine and Translational Medicine, University of Tartu</institution><addr-line><named-content content-type="city">Tartu</named-content></addr-line><country>Estonia</country></aff><aff id="aff2"><label>2</label><institution>Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution>Andrology Unit, Tartu University Hospital</institution><addr-line><named-content content-type="city">Tartu</named-content></addr-line><country>Estonia</country></aff><aff id="aff4"><label>4</label><institution>Institute of Clinical Medicine, University of Tartu</institution><addr-line><named-content content-type="city">Tartu</named-content></addr-line><country>Estonia</country></aff><aff id="aff5"><label>5</label><institution>Institute of Genomics, Estonian Biocentre, University of Tartu</institution><addr-line><named-content content-type="city">Tartu</named-content></addr-line><country>Estonia</country></aff><aff id="aff6"><label>6</label><institution>Department of Genetics &amp; Genome Biology, University of Leicester</institution><addr-line><named-content content-type="city">Leicester</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff7"><label>7</label><institution>Women’s Clinic, Tartu University Hospital</institution><addr-line><named-content content-type="city">Tartu</named-content></addr-line><country>Estonia</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Perry</surname><given-names>George H</given-names></name><role>Reviewing Editor</role><aff><institution>Pennsylvania State University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Perry</surname><given-names>George H</given-names></name><role>Senior Editor</role><aff><institution>Pennsylvania State University</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>30</day><month>03</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e65420</elocation-id><history><date date-type="received" iso-8601-date="2020-12-03"><day>03</day><month>12</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-03-15"><day>15</day><month>03</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Hallast et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Hallast et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65420-v1.pdf"/><abstract><p>Male infertility is a prevalent condition, affecting 5–10% of men. So far, few genetic factors have been described as contributors to spermatogenic failure. Here, we report the first re-sequencing study of the Y-chromosomal <italic>Azoospermia Factor c</italic> (<italic>AZFc</italic>) region, combined with gene dosage analysis of the multicopy <italic>DAZ, BPY2</italic>, and <italic>CDY</italic>genes and Y-haplogroup determination. In analysing 2324 Estonian men, we uncovered a novel structural variant as a high-penetrance risk factor for male infertility. The Y lineage R1a1-M458, reported at &gt;20% frequency in several European populations, carries a fixed ~1.6 Mb <italic>r2/r3</italic> inversion, destabilizing the <italic>AZFc</italic> region and predisposing to large recurrent microdeletions. Such complex rearrangements were significantly enriched among severe oligozoospermia cases. The carrier vs non-carrier risk for spermatogenic failure was increased 8.6-fold (p=6.0×10<sup>−4</sup>). This finding contributes to improved molecular diagnostics and clinical management of infertility. Carrier identification at young age will facilitate timely counselling and reproductive decision-making.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>idiopathic male infertility</kwd><kwd>y-chromosomal azfc region</kwd><kwd>gr/gr</kwd><kwd>b2/b3 deletions</kwd><kwd>complex structural rearrangements</kwd><kwd>y haplogroup r1a1-m458</kwd><kwd>daz, bpy2, cdy1 dosage</kwd><kwd>variants</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002301</institution-id><institution>Estonian Research Council</institution></institution-wrap></funding-source><award-id>PUT1036</award-id><principal-award-recipient><name><surname>Hallast</surname><given-names>Pille</given-names></name><name><surname>Kibena</surname><given-names>Laura</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002301</institution-id><institution>Estonian Research Council</institution></institution-wrap></funding-source><award-id>PUT181</award-id><principal-award-recipient><name><surname>Punab</surname><given-names>Margus</given-names></name><name><surname>Poolamets</surname><given-names>Olev</given-names></name><name><surname>Pomm</surname><given-names>Kristjan</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>098051</award-id><principal-award-recipient><name><surname>Hallast</surname><given-names>Pille</given-names></name><name><surname>Kibena</surname><given-names>Laura</given-names></name><name><surname>Arciero</surname><given-names>Elena</given-names></name><name><surname>Xue</surname><given-names>Yali</given-names></name><name><surname>Tyler-Smith</surname><given-names>Chris</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002301</institution-id><institution>Estonian Research Council</institution></institution-wrap></funding-source><award-id>IUT34-12</award-id><principal-award-recipient><name><surname>Kibena</surname><given-names>Laura</given-names></name><name><surname>Grigorova</surname><given-names>Marina</given-names></name><name><surname>Rull</surname><given-names>Kristiina</given-names></name><name><surname>Laan</surname><given-names>Maris</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002301</institution-id><institution>Estonian Research Council</institution></institution-wrap></funding-source><award-id>IUT24-1</award-id><principal-award-recipient><name><surname>Rootsi</surname><given-names>Siiri</given-names></name><name><surname>Flores</surname><given-names>Rodrigo</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002301</institution-id><institution>Estonian Research Council</institution></institution-wrap></funding-source><award-id>MOBTT53</award-id><principal-award-recipient><name><surname>Rootsi</surname><given-names>Siiri</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100008530</institution-id><institution>European Regional Development Fund</institution></institution-wrap></funding-source><award-id>3.2.0701.12-004</award-id><principal-award-recipient><name><surname>Punab</surname><given-names>Margus</given-names></name><name><surname>Rull</surname><given-names>Kristiina</given-names></name><name><surname>Laan</surname><given-names>Maris</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002301</institution-id><institution>Estonian Research Council</institution></institution-wrap></funding-source><award-id>PRG1021</award-id><principal-award-recipient><name><surname>Punab</surname><given-names>Margus</given-names></name><name><surname>Rull</surname><given-names>Kristiina</given-names></name><name><surname>Laan</surname><given-names>Maris</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>In addition to its academic merits, characterizing the genetic determinants of male (in)fertility and identifying clinically actionable genetic variants can lead to improved diagnosis or even treatment of such conditions.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The diagnosis of male factor infertility due to abnormal semen parameters concerns ~10% of men (<xref ref-type="bibr" rid="bib18">Jungwirth et al., 2012</xref>; <xref ref-type="bibr" rid="bib7">Datta et al., 2016</xref>). In today’s andrology workup, ~60% of patients with spermatogenic failure remain idiopathic (<xref ref-type="bibr" rid="bib37">Punab et al., 2017</xref>). Among the known causes, the most widely considered genetic factors are karyotype abnormalities (up to 17% of patients) and recurrent de novo microdeletions of the Y-chromosomal <italic>Azoospermia Factor</italic> <italic>a </italic>(<italic>AZFa</italic>) (~0.8 Mb), <italic>AZFb</italic> (~6.2 Mb), and <italic>AZFc</italic> (~3.5 Mb) regions (2–10%) (<xref ref-type="bibr" rid="bib37">Punab et al., 2017</xref>; <xref ref-type="bibr" rid="bib35">Olesen et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Tüttelmann et al., 2011</xref>). For more than 15 years, testing for <italic>AZF</italic> deletions has been strongly recommended in the diagnostic workup for infertility patients with sperm concentration of &lt;5 × 10<sup>6</sup>/ml (<xref ref-type="bibr" rid="bib2">ASRM, 2015</xref>; <xref ref-type="bibr" rid="bib23">Krausz et al., 2014</xref>). Most deletion carriers represent patients with either azoospermia (no sperm) or cryptozoospermia (&gt;0–1 million sperm/ejaculate) (<xref ref-type="bibr" rid="bib37">Punab et al., 2017</xref>; <xref ref-type="bibr" rid="bib21">Kohn et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Stahl et al., 2010</xref>). The most prevalent deletion type is <italic>AZFc</italic> (~80%), followed by the loss of <italic>AZFa</italic> (0.5–4%), <italic>AZFb</italic> (1–5%), and <italic>AZFbc</italic> (1–3%) regions (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Excess of recurrent <italic>AZFc</italic> deletions is promoted by the region’s complex genomic structure comprised of long direct and inverted amplicons of nearly identical DNA segments that lead to aberrant meiotic rearrangements in gametogenesis (<xref ref-type="bibr" rid="bib25">Kuroda-Kawaguchi et al., 2001</xref>; <xref ref-type="bibr" rid="bib44">Skaletsky et al., 2003</xref>; <xref ref-type="fig" rid="fig1">Figure 1B</xref>). The <italic>AZFc</italic> full deletions remove all the multicopy <italic>DAZ (deleted in azoospermia 1)</italic>, <italic>BPY2 (basic charge Y-linked 2)</italic>, and <italic>CDY1</italic> (<italic>chromodomain Y-linked 1</italic>) genes that are expressed in a testis-enriched manner and considered important in spermatogenesis (<xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Y-chromosomal <italic>AZFc</italic> region and its partial deletions in the study group.</title><p>(<bold>A</bold>) Schematic representation of the human Y chromosome with the <italic>AZFa</italic>, <italic>AZFb</italic>, and <italic>AZFc</italic> regions shown as black bars. (<bold>B</bold>) Magnified structure of the <italic>AZFc</italic> region with approximate locations of multicopy protein-coding genes, STS (sY) markers for the detection of <italic>AZFc</italic> partial deletions and the span of typical <italic>gr/gr</italic> and <italic>b2/b3</italic> deletions (<xref ref-type="bibr" rid="bib25">Kuroda-Kawaguchi et al., 2001</xref>). P1–P3 (gray triangles) denote palindromic genomic segments consisting of two ‘arms’ representing highly similar inverted DNA repeats (&gt;99.7% sequence identity) that flank a relatively short distinct ‘spacer’ sequence. Of note, the occurrence of the <italic>b2/b3</italic> deletion requires a preceding inversion in the <italic>AZFc</italic> region and therefore its presentation on the reference sequence includes also the retained segment (gray dashed line). Full details about alternative <italic>gr/gr</italic> and <italic>b2/b3</italic> deletion types are presented in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>. (<bold>C</bold>) Dosage of multicopy genes on human Y chromosomes with or without <italic>AZFc</italic> deletions. (<bold>D</bold>) Prevalence of the <italic>gr/gr</italic> and <italic>b2/b3</italic> deletions detected in the subgroups of this study. Fisher’s exact test was used to test the statistical significance in the deletion frequencies between the groups. PAR, pseudoautosomal region; MSY, male-specific region of the Y chromosome; cen, centromere; <italic>AZF</italic>, azoospermia factor region.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65420-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>The human Y chromosome and the <italic>Azoospermia Factor (AZF)</italic> regions.</title><p>(<bold>A</bold>) The human Y chromosome drawn to approximate scale with regions of <italic>AZFa</italic>, <italic>AZFb</italic>, and <italic>AZFc</italic> deletions shown below as black bars. PAR, pseudoautosomal region; MSY, male-specific region of the Y chromosome; cen, centromere; <italic>AZF,</italic> azoospermia factor region. (<bold>B</bold>) Structure of the <italic>AZFc</italic> region on human Y-chromosomal reference sequence with approximate locations of protein-coding genes and STS (sY) markers used for detection of partial <italic>AZFc</italic> deletions (<xref ref-type="bibr" rid="bib25">Kuroda-Kawaguchi et al., 2001</xref>). Alternative involved regions in <italic>gr/gr</italic> deletions arising on (<bold>C</bold>). The human Y-chromosomal reference sequence and (<bold>D</bold>) the Y chromosome with a preceding <italic>b3/b4</italic> inversion. The approximate region removed by each deletion is shown as a dashed line. (<bold>E</bold>) Structure of the <italic>AZFc</italic> region undergone the <italic>gr/gr</italic> deletion and the proposed model of homologous recombination leading to the subsequent ‘<italic>b2/b4</italic>’ duplication. The light blue box denotes the recombination targets. The duplication is presumably the result of recombination between sister chromatids. (<bold>F</bold>) Reported models for <italic>b2/b3</italic> deletions arising on the Y chromosomes with preceding <italic>b2/b3</italic> or <italic>g1/g3</italic> inversions. The approximate region removed by each deletion is shown as a dashed line. (<bold>G</bold>) Structure of the <italic>AZFc</italic> region undergone the <italic>b2/b3</italic> deletion and the proposed model of homologous recombination leading to the subsequent ‘<italic>b2/b4</italic>’ duplication. The light blue box denotes the recombination targets. The duplication is presumably the result of recombination between sister chromatids.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65420-fig1-figsupp1-v1.tif"/></fig></fig-group><p>The palindromic structure of the <italic>AZFc</italic> region also facilitates partial deletions that are rather frequently detected in the general population (<xref ref-type="bibr" rid="bib39">Repping et al., 2003</xref>; <xref ref-type="bibr" rid="bib40">Repping et al., 2004</xref>; <xref ref-type="bibr" rid="bib42">Rozen et al., 2012</xref>; <xref ref-type="bibr" rid="bib10">Fernandes et al., 2004</xref>). The most prevalent partial deletion types, named after the involved amplicons as <italic>g(reen)-r(ed)/g(reen)-r(ed)</italic> (lost segment ~1.6 Mb) and <italic>b(lue)2/b(lue)3</italic> (~1.8 Mb) reduce the copy number of <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY1</italic> genes by roughly 50% (<xref ref-type="fig" rid="fig1">Figure 1B,C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). The published data on the contribution of <italic>gr/gr</italic> and <italic>b2/b3</italic> deletions to spermatogenic failure are inconsistent. In European populations, the carrier status of the <italic>gr/gr</italic> deletion increases a risk to low sperm counts ~1.8-fold (<xref ref-type="bibr" rid="bib42">Rozen et al., 2012</xref>; <xref ref-type="bibr" rid="bib3">Bansal et al., 2016a</xref>; <xref ref-type="bibr" rid="bib22">Krausz et al., 2009</xref>). Its more variable effect on spermatogenesis has been shown in Middle Eastern and Asian populations, where the <italic>gr/gr</italic> deletion is completely fixed in some Y lineages, for example haplogroups D2 and Q1a that are common in Japan and some parts of China (<xref ref-type="bibr" rid="bib8">de Carvalho et al., 2006</xref>; <xref ref-type="bibr" rid="bib46">Teitz et al., 2018</xref>). In contrast, the <italic>b2/b3</italic> deletion appears to be a risk factor for spermatogenic impairment in several East Asian and African, but not in European or South Asian populations (<xref ref-type="bibr" rid="bib4">Bansal et al., 2016b</xref>; <xref ref-type="bibr" rid="bib5">Colaco and Modi, 2018</xref>). Notably, the <italic>b2/b3</italic> deletion is completely fixed in Y haplogroup N3 that has a high frequency (up to 90% in some populations) in Finno-Ugric-, Baltic-, and some Turkic-speaking people living in Northern Eurasia (<xref ref-type="bibr" rid="bib42">Rozen et al., 2012</xref>; <xref ref-type="bibr" rid="bib10">Fernandes et al., 2004</xref>; <xref ref-type="bibr" rid="bib15">Ilumäe et al., 2016</xref>). Thus, it is unlikely that the carriership of a <italic>gr/gr</italic> or <italic>b2/b3</italic> deletion per se has an effect on male fertility potential. It has been proposed that this broad phenotypic variability may be explained by the diversity of <italic>gr/gr</italic> and <italic>b2/b3</italic> deletion subtypes (<xref ref-type="bibr" rid="bib31">Machev, 2004</xref>). Y chromosomes carrying partial <italic>AZFc</italic> deletions may differ for the content, dosage, or genetic variability of the retained genes, the overall genetic composition reflected by phylogenetic haplogroups or the presence of additional structural variants. Only limited studies have analyzed the subtypes of <italic>gr/gr</italic> or <italic>b2/b3</italic> deletions, and no straightforward conclusions have been reached for their link to spermatogenic failure (<xref ref-type="bibr" rid="bib22">Krausz et al., 2009</xref>; <xref ref-type="bibr" rid="bib11">Ghorbel et al., 2016</xref>; <xref ref-type="bibr" rid="bib24">Krausz and Casamonti, 2017</xref>).</p><p>The current study represents the largest in-depth investigation of <italic>AZFc</italic> partial deletions in men recruited by a single European clinical center. We analysed 1190 Estonian idiopathic patients with male factor infertility in comparison to 1134 reference men from the same population, including 2000 subjects with sperm parameter data available. Y chromosomes carrying <italic>gr/gr</italic> or <italic>b2/b3</italic> deletions were investigated for additional genomic rearrangements, Y-chromosomal haplogroups, and dosage and sequence variation of the retained <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY</italic> genes. The study aimed to determine the role and contribution of <italic>gr/gr</italic> and <italic>b2/b3</italic> deletion subtypes in spermatogenic failure and to explore their potential in the clinical perspective.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Enrichment of <italic>gr/gr</italic> deletions in Estonian idiopathic infertile men with reduced sperm counts</title><p>The study analyzed 1190 Estonian men with idiopathic infertility (sperm counts 0–39 × 10<sup>6</sup>/ejaculate) and a reference group comprised of 1134 Estonian men with proven fatherhood (n = 635) or representing healthy young men (n = 499) (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). For all 2324 study subjects, complete <italic>AZFa</italic>, <italic>AZFb</italic>, and <italic>AZFc</italic> deletions were excluded.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Characteristics of the patients with male factor infertility and reference groups used for comparison.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom"/><th valign="bottom"/><th colspan="3" valign="bottom">Idiopathic spermatogenic impairment (n = 1190)*</th><th colspan="3" valign="bottom">Reference groups (n = 1134)</th></tr><tr><th valign="bottom">Parameter</th><th valign="bottom">Unit</th><th valign="bottom">Azoo-/cryptozoospermia</th><th valign="bottom">Severe oligozoospermia</th><th valign="bottom">Moderate oligozoospermia</th><th valign="bottom">Partners of pregnant women<sup>†</sup></th><th valign="bottom">Estonian young men cohort<sup>‡</sup></th><th valign="bottom">REPROMETA proven fathers<sup>§</sup></th></tr></thead><tbody><tr><td valign="bottom"/><td valign="bottom">n</td><td valign="top">104/88</td><td valign="top">319</td><td valign="top">679</td><td valign="top">324</td><td valign="top">499</td><td valign="top">311</td></tr><tr><td valign="top">Age</td><td valign="top">Years</td><td valign="top">33.2 <break/>(23.6–51.8)</td><td valign="top">32.2 <break/>(23.9–49.5)</td><td valign="top">31.7 <break/>(23.0–44.6)</td><td valign="top">31.0 <break/>(22.9–45.0)</td><td valign="top">18.6 <break/>(17.2–22.9)</td><td valign="top">31.0 <break/>(21.0–43.0)</td></tr><tr><td valign="top">BMI</td><td valign="top">kg/m<sup>2</sup></td><td valign="top">26.0 <break/>(21.2–34.4)</td><td valign="top">25.9 <break/>(20.2–35.5)</td><td valign="top">25.8 <break/>(20.1–34.6)</td><td valign="top">24.8 <break/>(20.0–32.2)</td><td valign="top">22.0 <break/>(18.7–27.5)</td><td valign="top">25.9 <break/>(20.2–33.1)</td></tr><tr><td valign="top">Total testis volume</td><td valign="top">ml</td><td valign="top">33.5 <break/>(17.0–49.0)</td><td valign="top">39.0 <break/>(22.0–50.0)</td><td valign="top">40.0 <break/>(26.0–52.0)</td><td valign="top">46.0 <break/>(34.0–62.4)</td><td valign="top">50.0 <break/>(35.0–70.0)</td><td valign="top">n.d.</td></tr><tr><td valign="top">Semen volume</td><td valign="top">ml</td><td valign="top">3.3 <break/>(0.8–6.6)</td><td valign="top">3.3 <break/>(1.1–7.0)</td><td valign="top">3.6 <break/>(1.6–6.9)</td><td valign="top">3.7 <break/>(1.7–8.0)</td><td valign="top">3.2 <break/>(1.2–6.4)</td><td valign="top">n.d.</td></tr><tr><td valign="top">Sperm concentration</td><td valign="top">× 10<sup>6</sup>/ml</td><td valign="top">0 <break/>(0–0.2)</td><td valign="top">1.4 <break/>(0.4–5.2)</td><td valign="top">6.0 <break/>(2.2–15.2)</td><td valign="top">76.0 <break/>(16.7–236.0)</td><td valign="top">66.8 <break/>(8.2–225.1)</td><td valign="top">n.d.</td></tr><tr><td valign="top">Total sperm count</td><td valign="top">× 10<sup>6</sup>/ ejaculate</td><td valign="top">0 <break/>(0–0.7)</td><td valign="top">4.7 <break/>(1.3–9.3)</td><td valign="top">23.1 <break/>(11.0–37.5)</td><td valign="top">295.2 <break/>(60.0–980.1)</td><td valign="top">221.6 <break/>(18.4–788.0)</td><td valign="top">n.d.</td></tr><tr><td valign="top">Progressive A+B motility</td><td valign="top">%</td><td valign="top">0 <break/>(0–37.2)</td><td valign="top">16.0 <break/>(0–47.2)</td><td valign="top">27.0 <break/>(1.0–57.0)</td><td valign="top">50.0 <break/>(30.0–69.0)</td><td valign="top">57.3 <break/>(34.7–75.3)</td><td valign="top">n.d.</td></tr><tr><td valign="top">Sperms with normal morphology</td><td valign="top">%</td><td valign="top">0 <break/>(0–1.0)</td><td valign="top">0 <break/>(0–6.0)</td><td valign="top">2.0 <break/>(0–9.0)</td><td valign="top">10.0 <break/>(2.0–19.1)</td><td valign="top">12.0 <break/>(4.0–20.0)</td><td valign="top">n.d.</td></tr><tr><td valign="top">FSH</td><td valign="top">IU/l</td><td valign="top">13.7 <break/>(2.7–38.2)</td><td valign="top">6.6 <break/>(1.9–22.8)</td><td valign="top">5.2 <break/>(1.8–16.5)</td><td valign="top">3.6 <break/>(1.5–8.3)</td><td valign="top">2.8 <break/>(1.2–6.7)</td><td valign="top">n.d.</td></tr><tr><td valign="top">LH</td><td valign="top">IU/l</td><td valign="top">5.7 <break/>(2.1–12.0)</td><td valign="top">4.6 <break/>(1.9–9.9)</td><td valign="top">4.2 <break/>(1.8–8.4)</td><td valign="top">3.6 <break/>(1.5–6.7)</td><td valign="top">3.8 <break/>(1.8–7.2)</td><td valign="top">n.d.</td></tr><tr><td valign="top">Total testosterone</td><td valign="top">nmol/l</td><td valign="top">15.3 <break/>(7.7–28.4)</td><td valign="top">16.6 <break/>(7.9–30.0)</td><td valign="top">16.6 <break/>(8.5–30.3)</td><td valign="top">16.5 <break/>(8.8–27.2)</td><td valign="top">27.7 <break/>(15.4–46.3)</td><td valign="top">n.d.</td></tr></tbody></table><table-wrap-foot><fn><p>All study subjects were recruited in Estonia. For each parameter, median and (5th–95th) percentile values are shown. Additional details in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p><p><sup>*</sup>Patients were subgrouped based on total sperm counts per ejaculate: azoospermia, no sperm; cryptozoospermia, sperm counts &gt; 0–1 × 10<sup>6</sup>; severe oligozoospermia, &gt;1–10 × 10<sup>6</sup>; moderate oligozoospermia, &gt;10–39 × 10<sup>6</sup> (<xref ref-type="bibr" rid="bib37">Punab et al., 2017</xref>).</p></fn><fn><p><sup>†</sup>Male partners of pregnant women (<xref ref-type="bibr" rid="bib37">Punab et al., 2017</xref>); eight men had sperm counts &lt; 39 × 10<sup>6</sup>; for four men, sperm analysis was not available.</p><p><sup>‡</sup>Male cohort without fatherhood data (<xref ref-type="bibr" rid="bib13">Grigorova et al., 2008</xref>); 47 men had sperm counts &lt; 39 × 10<sup>6</sup>; for nine men, sperm analysis was not available.</p></fn><fn><p><sup>§</sup>REPROMETA study recruited and sampled couples after delivery of their newborn; details in <xref ref-type="bibr" rid="bib20">Kikas et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Pilvar et al., 2019</xref>.</p><p>n.d., not determined.</p></fn></table-wrap-foot></table-wrap><p>The partial <italic>AZFc</italic> deletions identified using the STS-based polymerase chain reaction (PCR) assays were <italic>gr/gr</italic> (n = 46), <italic>b2/b3</italic> (n = 756), and <italic>b1/b3</italic> (n = 1, reference case) (<xref ref-type="table" rid="table2">Table 2</xref>). A statistically significant excess of <italic>gr/gr</italic> deletions was detected in idiopathic male infertility patients (2.7%; n = 32/1190) compared to reference cases (1.2%; n = 14/1134) (Fisher’s exact test, p=0.016; odds ratio [OR] = 2.2 [95% confidence interval (CI) 1.2–4.2]) (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). The highest frequency of <italic>gr/gr</italic> deletion carriers (6.8%, n = 6/88) was detected in cryptozoospermia cases (sperm count &gt; 0–1 × 10<sup>6</sup>/ejaculate). However, in the reference group andrological parameters of men with or without the <italic>gr/gr</italic> deletion did not differ (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). All 10 reference men with the <italic>gr/gr</italic> deletion and available andrological data were normozoospermic (220.3 [74.2–559.0] × 10<sup>6</sup> sperm/ejaculate). Also their other andrological parameters were within the normal range, overlapping with those of the subjects without a <italic>gr/gr</italic> deletion.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Summary of the identified Y-chromosomal <italic>AZF</italic> deletion subtypes.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Y-chromosomal rearrangements</th><th valign="bottom">Idiopathic male infertility patients (n)</th><th valign="bottom">Reference men (n)</th></tr></thead><tbody><tr><td valign="bottom">All analyzed cases</td><td valign="bottom">1190</td><td valign="bottom">1134</td></tr><tr><td valign="top">Any <italic>AZFc gr/gr</italic> deletion</td><td valign="bottom">32 (2.7%)</td><td valign="bottom">14 (1.2%)</td></tr><tr><td valign="bottom"/><td colspan="2" valign="bottom">Fisher’s exact test, p=0.016; OR = 2.2 [95% CI 1.2–4.2]</td></tr><tr><td valign="bottom">Any <italic>AZFc b2/b3</italic> deletion</td><td valign="bottom">388 (32.6%)</td><td valign="bottom">367 (32.4%)</td></tr><tr><td valign="top">Other type of <italic>AZF</italic> deletion</td><td valign="bottom">Loss of <italic>b2/b3</italic> marker sY1191 (one case)</td><td valign="bottom"><italic>AZFc b1/b3</italic> del (one case); partial <italic>AZFa</italic> del (one case)</td></tr><tr><td valign="top">No deletion</td><td valign="bottom">769 (64.6%)</td><td valign="bottom">751 (66.2%)</td></tr><tr><td colspan="3" valign="bottom"><italic>Simple partial AZFc deletions</italic></td></tr><tr><td valign="bottom">Typical <italic>gr/gr</italic> deletion</td><td valign="bottom">19/31 (61.3%)</td><td valign="bottom">8/13 (61.5%)</td></tr><tr><td valign="bottom">Typical <italic>b2/b3</italic> deletion*</td><td valign="bottom">300/382 (78.5%)</td><td valign="bottom">210/249 (84.3%)</td></tr><tr><td colspan="3" valign="bottom"><italic>AZFc partial deletion followed by b2/b4 duplication</italic></td></tr><tr><td valign="bottom"><italic>gr/gr</italic> del + <italic>b2/b4</italic> dupl<sup>†</sup></td><td valign="bottom">2/31 (6.5%)</td><td valign="bottom">3/13 (23.1%)</td></tr><tr><td valign="bottom"/><td colspan="2" valign="bottom">Fisher’s exact test, p=0.144; OR = 0.2 [95% CI 0.0–1.6]</td></tr><tr><td valign="bottom"><italic>b2/b3</italic> del + <italic>b2/b4</italic> dupl<sup>*,†</sup></td><td valign="bottom">78/382 (20.4%)</td><td valign="bottom">34/249 (13.7%)</td></tr><tr><td valign="bottom"/><td colspan="2" valign="bottom">Fisher’s exact test, p=0.026; OR = 1.6 [95% CI 1.0–2.4]</td></tr><tr><td colspan="3" valign="bottom"><italic>AZFc partial deletion and atypical genomic rearrangements</italic><sup>‡</sup></td></tr><tr><td valign="bottom"><italic>gr/gr</italic> del + extra gene copies</td><td valign="bottom">1</td><td valign="bottom">0</td></tr><tr><td valign="bottom"><italic>b2/b3</italic> del + extra gene copies</td><td valign="bottom">3</td><td valign="bottom">4</td></tr><tr><td colspan="3" valign="bottom"><italic>Complex events on the Y lineage R1a1-M458 with the preceding AZFc r2/r3 inversion</italic></td></tr><tr><td valign="bottom"><italic>r2/r3</italic> inv <italic>+ gr/gr</italic> del</td><td valign="bottom">8</td><td valign="bottom">2<sup>§</sup></td></tr><tr><td valign="bottom"><italic>r2/r3</italic> inv <italic>+ gr/gr</italic> del + <italic>b2/b4</italic> dupl</td><td valign="bottom">1</td><td valign="bottom">0</td></tr><tr><td valign="bottom"><italic>r2/r3</italic> inv + loss of marker sY1191 + secondary gene duplications<sup>¶</sup></td><td valign="top">1</td><td valign="top">0</td></tr><tr><td valign="bottom"><italic>r2/r3</italic> inv <italic>+ b2/b3</italic> del + <italic>b2/b4</italic> dupl</td><td valign="bottom">0</td><td valign="bottom">1**</td></tr><tr><td colspan="3" valign="bottom"><italic>Carriers of any AZFc gr/gr deletion type without the preceding r2/r3 inversion</italic></td></tr><tr><td valign="bottom"><italic>gr/gr</italic> del w/o detected <italic>r2/r3</italic> inv</td><td valign="bottom">23/1190 (1.9 %)</td><td valign="bottom">12/1134 (1.1%)</td></tr><tr><td valign="bottom"/><td colspan="2" valign="bottom">Fisher’s exact test, p=0.090; OR = 1.8 [95% CI 0.9–3.7]</td></tr></tbody></table><table-wrap-foot><fn><p>*Deletion subtype analysis was carried out for cases with available sufficient quantities of DNA. REPROMETA subjects were excluded from the <italic>b2/b3</italic> deletion subtype analysis and subsequent statistical testing due to missing andrological data.</p><p><sup>†</sup>One or more amplicons of the retained ‘2x<italic>DAZ</italic>, 2x<italic>BPY2</italic>, 1x<italic>CDY1</italic>’ (<italic>gr/gr</italic> deletion) or ‘2x<italic>DAZ</italic>, 1x<italic>BPY2</italic>, 1x<italic>CDY1’</italic> (<italic>b2/b3</italic> deletion) genes.</p></fn><fn><p><sup>‡</sup>Additional copies of <italic>DAZ</italic>, <italic>BPY2</italic>, and/or <italic>CDY1</italic> genes inconsistent with the full ‘<italic>b2/b4</italic>’ duplication.</p><p><sup>§</sup>Including one REPROMETA man without andrological data.</p></fn><fn><p><sup>¶</sup>Detected gene copy numbers 6x<italic>DAZ</italic>, 4x<italic>BPY2,</italic> 3x<italic>CDY1</italic>; the obligate presence of <italic>r2/r3</italic> inversion was defined based on Y-chromosomal phylogeny as the man carries Y lineage R1a1a1b1a1a1c-CTS11962.1 that was also identified in two cases with the <italic>r2/r3</italic> inversion (<xref ref-type="supplementary-material" rid="supp12">Supplementary file 12</xref>).</p><p>**Man from ‘Partners of pregnant women’ cohort with sperm concentration 12 × 10<sup>6</sup>/ml below normozoospermia threshold (15 × 10<sup>6</sup>/ml) and sperm counts 39.4 × 10<sup>6</sup>/ejaculate at the borderline of the lowest reference value (39.0 × 10<sup>6</sup>/ejaculate).</p></fn></table-wrap-foot></table-wrap><p>The patient and the reference groups exhibited similar prevalence of <italic>b2/b3</italic> deletions (388/1190, 32.6% vs 367/1134, 32.4%; Fisher’s exact test, p=0.8). No apparent clinically meaningful genetic effects on andrological parameters were observed in either of the study groups (<xref ref-type="supplementary-material" rid="supp3">Supplementary files 3</xref> and <xref ref-type="supplementary-material" rid="supp4">4</xref>).</p></sec><sec id="s2-2"><title>Significant overrepresentation of Y lineage R1a1-M458 in <italic>gr/gr</italic> deletion carriers</title><p>The Y-chromosomal haplogroups determined by typing phylogenetically informative markers in 31 patients and 13 reference men carrying a <italic>gr/gr</italic> deletion represented 20 different lineages (patients, 17; reference men, 10; <xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). Combining the phylogenetic context with the data on exact missing <italic>DAZ</italic> and <italic>CDY1</italic> gene copies (see below) revealed that the <italic>gr/gr</italic> deletion events in 44 analyzed cases must have independently occurred at least 26 times. About two-thirds of these Y chromosomes belonged to haplogroup R1, whereas the rest represented A1b, G, I, and J lineages. Notably, there was a highly significant overrepresentation of Y chromosomes belonging to lineage R1a1-M458 in the <italic>gr/gr</italic> deletion carriers compared to the known Estonian population frequency (22.7% vs 5.1%; Fisher’s exact test, p=5.3×10<sup>−4</sup>, OR = 5.5 [95% CI 2.2–13.7]; <xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>; <xref ref-type="bibr" rid="bib49">Underhill et al., 2015</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Phylogenetic relationships and gene copies in study subjects with partial <italic>AZFc</italic> deletions.</title><p>(<bold>A</bold>) Y-chromosomal lineages indicated with typed terminal markers (left), deleted (white)/retained (black) <italic>DAZ</italic> and <italic>CDY1</italic> gene copies (middle), and secondary rearrangements in the <italic>AZFc</italic> region (right) of idiopathic male factor infertility (n = 31) and reference cases (n = 13) carrying the <italic>gr/gr</italic> deletion. The human Y-chromosomal reference sequence has four <italic>DAZ</italic> and two <italic>CDY1</italic> copies; the retained gene copies on each Y chromosome with a <italic>gr/gr</italic> deletion are shown as filled boxes. Chromosomes carrying atypical <italic>gr/gr</italic> subtypes with the loss of either the <italic>DAZ1/DAZ3</italic> or <italic>DAZ2/DAZ4</italic> gene pair due to complex genomic rearrangement combining the previous <italic>r2/r3</italic> inversion with a subsequent <italic>gr/gr</italic> deletion are highlighted with a dashed gray square. (<bold>B</bold>) Enrichment of the Y-chromosomal lineage R1a1-M458 and its sub-lineages in study subjects carrying the <italic>gr/gr</italic> deletion in comparison to the Estonian general population (data from <xref ref-type="bibr" rid="bib49">Underhill et al., 2015</xref>). Fisher’s exact test was used to test the statistical significance between the groups. (<bold>C</bold>) Y-chromosomal lineages indicated with typed terminal markers (left) and the copy number of the <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY1</italic> gene copies (right) determined for 382 idiopathic male factor infertility cases carrying the <italic>b2/b3</italic> deletion. The light gray box denotes <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY1</italic> gene dosage consistent with full <italic>b2/b4</italic> duplication(s). The legend for the deletion subtype is shown in the bottom right corner. Further information on the distribution of Y-chromosomal lineages in the carriers of <italic>AZFc</italic> partial deletions are provided in <xref ref-type="supplementary-material" rid="supp5">Supplementary files 5</xref> and <xref ref-type="supplementary-material" rid="supp6">6</xref>, and the <italic>AZFc</italic> rearrangement types are detailed in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> and <xref ref-type="supplementary-material" rid="supp7">Supplementary files 7</xref> and <xref ref-type="supplementary-material" rid="supp9">9</xref>–<xref ref-type="supplementary-material" rid="supp12">12</xref>. n, number; n.a., not available; Ref, reference cases.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65420-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Histograms of estimated raw copy number values for <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY</italic> genes by ddPCR.</title><p>(<bold>A</bold>) Distribution of copy number estimates for all typed samples (n = 675); (<bold>B</bold>) samples carrying the <italic>b2/b3</italic> or sY1191 marker deletions (n = 631); and (<bold>C</bold>) samples carrying the <italic>gr/gr</italic> deletion (n = 44). The <italic>CDY</italic> gene copy number is a sum of <italic>CDY1</italic> and <italic>CDY2</italic> (assumed to be two) copy numbers. Note: one patient with a <italic>gr/gr</italic> deletion appeared to carry a single copy of <italic>DAZ</italic> gene (ddPCR repeated four times). However, both the Illumina re-sequencing data and paralogous sequence variant (PSV) typing were consistent with two copies of <italic>DAZ</italic> genes being retained, and therefore in all downstream analysis, the presence of two <italic>DAZ</italic> genes was assumed. The likely reason for the discrepancy between ddPCR and re-sequencing/PSV typing is a disruption of ddPCR primer or probe binding site.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65420-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Location of the identified exonic variants in the <italic>DAZ</italic> genes.</title><p>(<bold>A</bold>) Schematic representation of the human Y-chromosomal reference sequence containing the <italic>AZFc</italic> region, with approximate locations of protein-coding genes and their direction of transcription shown as black triangles. Direct and inverted repeats with highly similar DNA sequences are denoted as coloured arrows. (<bold>B</bold>) The structure of human <italic>DAZ</italic> genes, modified from <xref ref-type="bibr" rid="bib9">Fernandes et al., 2002</xref> to represent the human Y-chromosomal reference sequence (GRCh38). Blue dashed arrows show the direction of transcription. Exons with high DNA sequence similarity within and between <italic>DAZ</italic> genes are denoted with the same fill colour. The number of highly similar exon seven copies (in yellow) varies between genes and copies marked with the same letter denote identical sequences. Numbers below the gene structure denote exonic variants. 1 – DAZ1 p.H173Y or DAZ2 p.H173Y. 2 – DAZ1 p.Q262E or DAZ2 p.Q262E. 3 – DAZ1 p.Y243C or DAZ2 p.Y219C. 4 – potential splicing variant in <italic>DAZ3</italic> or <italic>DAZ4</italic>. Black squares in <italic>DAZ4</italic> denote the deleted exons 7f and 7y in Y lineages I1 and R1a1a1b1a2, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65420-fig2-figsupp2-v1.tif"/></fig></fig-group><p>Nearly all (99.4%) Estonian cases with the <italic>b2/b3</italic> deletion belonged to the Y haplogroup N3, in which this event is fixed (<xref ref-type="bibr" rid="bib40">Repping et al., 2004</xref>; <xref ref-type="bibr" rid="bib10">Fernandes et al., 2004</xref>). The most commonly detected sub-lineage was N3a3a-L550 (~51% of 436 typed chromosomes) and in total 15 different haplogroups that had diverged after the <italic>b2/b3</italic> deletion event in the common ancestor of N3 were present in Estonian men (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). <italic>b2/b3</italic> Y chromosomes representing non-N3 lineages were detected in two patients and three reference men. Lineage typing was possible for three of them, who carried either K-M9 (one patient) or R1a1a1b1a1a1c-CTS11962.1 (one patient and one reference case).</p></sec><sec id="s2-3"><title>Increased prevalence of <italic>b2/b3</italic> deletion followed by <italic>b2/b4</italic> duplication in infertile men</title><p>The expected retained copy number of <italic>DAZ, BPY2</italic>, and <italic>CDY1</italic> genes consistent with the typical <italic>gr/gr</italic> deletion, as determined by quantification using Droplet Digital PCR (ddPCR), was found in 37/44 (~84%) cases (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, <xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>). Three patients and three reference men carried a secondary <italic>b2/b4</italic> duplication adding one or more amplicons of [two <italic>DAZ</italic> – two <italic>BPY2</italic> – one <italic>CDY1</italic>] genes with no apparent effect on infertility status (Fisher’s exact test, p=0.34). Notably, four of six samples with secondary <italic>b2/b4</italic> duplication events were identified in haplogroup I. This complex rearrangement has also been reported in the gnomAD SV database (v 2.1) in 114/5528 analyzed men from around the world with the prevalence of 3.5% in East Asians and 1.2% in Europeans (<xref ref-type="supplementary-material" rid="supp8">Supplementary file 8</xref>; <xref ref-type="bibr" rid="bib6">Collins et al., 2020</xref>).</p><p>Similarly, 78.5% of patients and 84.3% reference men with the <italic>b2/b3</italic> deletion presented gene dosage consistent with the typical deletion (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, <xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="supplementary-material" rid="supp7">Supplementary files 7 and</xref> <xref ref-type="supplementary-material" rid="supp9">9</xref>). Indicative of recurrent secondary events, one or more <italic>b2/b4</italic> duplications of [two <italic>DAZ</italic> – one <italic>BPY2</italic> – one <italic>CDY1</italic>] genes were identified in 13 haplogroups, including non-N3 lineages K-M9 and R1a1a1b1a1a1c-CTS11962.1. In the gnomAD, 58/5115 men have been reported with this duplication, with the prevalence of 2.2% in East Asians and 0.9% in Europeans (<xref ref-type="supplementary-material" rid="supp8">Supplementary file 8</xref>). Although secondary <italic>b2/b4</italic> duplications were detected with significantly higher prevalence in patients compared to the reference men (n = 78/382, 20.4% vs n = 35/249, 14.1%; Fisher’s exact test, p=0.026, OR = 1.57 [95% CI 1.02–2.42]), no consistent effect of increased gene copy number on andrological parameters was observed (<xref ref-type="supplementary-material" rid="supp3">Supplementary files 3</xref> and <xref ref-type="supplementary-material" rid="supp4">4</xref>). Reference men with <italic>b2/b4</italic> duplication compared to subjects with no <italic>AZFc</italic> rearrangements showed a trend for lower follicle-stimulating hormone (FSH) (median 2.3 [5–95% range 1.4–7.5] vs 3.2 [1.3–7.1] IU/l; p&lt;0.05) and luteinizing hormone (LH) (3.1 [1.7–5.0] vs 3.8 (1.7–7.2) IU/l; p&lt;0.05). Additionally, in eight subjects with <italic>AZFc</italic> partial deletions, further atypical Y-chromosomal genomic rearrangements were detected, but also with no clear evidence for a phenotypic effect (<xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>).</p><p>The data gathered from this analysis thus suggest that the dosage of <italic>DAZ, BPY2</italic>, and <italic>CDY1</italic> genes does not play a major role in modulating the pathogenic effect of the <italic>gr/gr</italic> and <italic>b2/b3</italic> deletions.</p></sec><sec id="s2-4"><title>No specific <italic>DAZ</italic> or <italic>CDY1</italic> gene copy is lost in men with spermatogenic failure</title><p>The deletion subtypes for <italic>b2/b3</italic> and <italic>gr/gr</italic> carriers were identified by determining the genotypes of <italic>DAZ</italic> and <italic>CDY1</italic> gene-specific paralogous sequence variants. The major <italic>b2/b3</italic> deletion subtype in both patients (99.7%) and reference cases (98.1%) was the loss of <italic>DAZ3-DAZ4-CDY1a</italic> genes, whereas the most frequent <italic>gr/gr</italic> subtypes among all the deletion carriers were the loss of <italic>DAZ1-DAZ2-CDY1a</italic> (41.9%, 18/43 cases) and <italic>DAZ1-DAZ2-CDY1b</italic> (25.6%, 11/43 cases) combinations (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="supplementary-material" rid="supp10">Supplementary files 10</xref> and <xref ref-type="supplementary-material" rid="supp11">11</xref>). The observed prevalence of the major <italic>gr/gr</italic> subtypes was concordant with the published data on other European populations (42.5% and 25.5%, respectively; <xref ref-type="bibr" rid="bib22">Krausz et al., 2009</xref>). As these <italic>gr/gr</italic> deletion subtypes are prevalent in the reference group (total 11 of 13, 84.6%), their major role in spermatogenic impairment can be ruled out. As a novel insight, a subset of these Y chromosomes showed lineage-specific loss of some exon 7 subtypes of the retained <italic>DAZ4</italic> gene (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>; <xref ref-type="supplementary-material" rid="supp11">Supplementary file 11</xref>). All five exons 7Y in the <italic>DAZ4</italic> gene were missing in the Y chromosomes with the <italic>DAZ1-DAZ2-CDY1a</italic> deletion that had occurred in sub-lineages of the R1a1a1b1a2 haplogroup (9/31 patients, 3/13 reference men), representing 12/18 <italic>DAZ1-DAZ2-CDY1a</italic> deletion carriers. The exon 7F in <italic>DAZ4</italic> was lost in haplogroup I1 and its sub-lineages (5/31, 2/13), that is 7/11 individuals carrying the <italic>DAZ1-DAZ2-CDY1b</italic> deletion (<xref ref-type="supplementary-material" rid="supp10">Supplementary files 10</xref> and <xref ref-type="supplementary-material" rid="supp11">11</xref>). There was no evidence that loss of <italic>DAZ4</italic> exons 7Y or 7F has any phenotypic consequences. Most likely, this observation reflects gene conversion events from <italic>DAZ3</italic> to <italic>DAZ4</italic> as the former lacks both, exons 7Y and 7F.</p><p>Taken together, our findings indicate that neither the loss of the <italic>DAZ1-DAZ2</italic> nor the <italic>DAZ3-DAZ4</italic> gene pair, combined with either a <italic>CDY1a</italic> or <italic>CDY1b</italic> gene, directly causes spermatogenic failure. Interestingly, no Y chromosomes were observed with fewer than two retained <italic>DAZ</italic> genes.</p></sec><sec id="s2-5"><title>Y lineage R1a1-M458 carries a fixed <italic>r2/r3</italic> inversion predisposing to recurrent deletions</title><p>Novel atypical <italic>gr/gr</italic> and <italic>b2/b3</italic> deletion subtypes with the loss of an unusual <italic>DAZ</italic> gene pair were identified (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="supplementary-material" rid="supp10">Supplementary files 10</xref>–<xref ref-type="supplementary-material" rid="supp12">12</xref>). Eight patients and two reference cases with a <italic>gr/gr</italic> deletion were missing <italic>DAZ2-DAZ4</italic> genes. Loss of <italic>DAZ1-DAZ3</italic> genes followed by a subsequent <italic>b2/b4</italic> duplication event was identified in one infertile and one reference case with either <italic>gr/gr</italic> or <italic>b2/b3</italic> deletion, respectively. All but one subject with this atypical pair of lost <italic>DAZ</italic> genes belonged to the Y haplogroup R1a1-M458 and its sub-lineages, significantly enriched in <italic>gr/gr</italic> deletion carriers (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). The most parsimonious explanation to explain the simultaneous deletion of either <italic>DAZ1-DAZ3</italic> or <italic>DAZ2-DAZ4</italic> genes is a preceding ~1.6 Mb long inversion between the <italic>r(ed)two</italic> and <italic>r(ed)three</italic> amplicons (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). This new inverted structure might be more susceptible to recurrent deletions as it has altered the internal palindromic structure of <italic>AZFc</italic> region. In <italic>r2/r3</italic> inversion chromosomes, the largest palindrome P1 is almost completely lost and the size of the palindrome P2 is greatly expanded by positioning the homologous <italic>g1/g2</italic> segments in an inverted orientation. The <italic>r2/r3</italic> inversion is consequently expected to destabilize the <italic>AZFc</italic> region as several long DNA amplicons with highly homologous DNA sequence are positioned in the same sequence orientation (<italic>b2</italic>, <italic>b3</italic>, and <italic>b4</italic>; <italic>g2</italic> and <italic>g3</italic>; <italic>y1</italic> and <italic>y3</italic>). Therefore, they are prone to non-allelic homologous recombination mediating recurrent deletions and duplications. Since these atypical deletion subtypes were identified only in a specific Y-chromosomal haplogroup, the detected <italic>r2/r3</italic> inversion must have occurred only once in the common ancestor of R1a1-M458 sub-lineages. One patient with the loss of <italic>DAZ2-DAZ4</italic> carried haplogroup R1a1a1-M417, an ancestral lineage to R1a1-M458 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). However, lineage R1a1a1-M417 is not fixed for this inversion since its other sub-lineage, R1a1a1b1a2, does not carry it and any subsequent inversion restoring the exact original <italic>AZFc</italic> structure is not credible. The more parsimonious explanation is that the inversion occurred in a sub-lineage of R1a1a1-M417 that has to be yet determined.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Complex structural variants at the Y-chromosomal lineage R1a1-M458 and their effect on andrological parameters.</title><p>(<bold>A</bold>) Schematic presentation of the Y chromosome with the <italic>r2/r3</italic> inversion compared to the reference sequence. The <italic>r2/r3</italic> inversion structure nearly destroys the large palindrome P1 and, consequently, destabilizes the <italic>AZFc</italic> region since several long DNA amplicons with highly similar DNA sequence (<italic>b2</italic>, <italic>b3</italic>, and <italic>b4</italic>; <italic>g2</italic> and <italic>g3</italic>; <italic>y1</italic> and y3) are positioned in the same sequence orientation. This structure promotes non-allelic homologous recombination mediating recurrent deletion and duplication events. The approximate regions removed by the identified <italic>gr/gr</italic> and <italic>b2/b3</italic> deletions arising on the <italic>r2/r3</italic> inverted Y chromosome are shown as dashed lines. (<bold>B</bold>) Distribution of andrological parameters in the idiopathic male factor infertility cases (total sperm counts 0–39 × 10<sup>6</sup>) subgrouped based on the structure of the <italic>AZFc</italic> region. The pairwise Wilcoxon rank-sum test was applied to estimate the statistical difference between groups (Bonferroni threshold for multiple testing correction, p&lt;1.0×10<sup>−3</sup>). Threshold values (shown in gray) for sperm parameters corresponding to severe spermatogenic failure are based on international guidelines (<xref ref-type="bibr" rid="bib51">World Health Organization, 2010</xref>). For reproductive hormones, reference values of the laboratory service provider are shown. The empirical threshold for the total testis volume was based on routinely applied clinical criteria at the AC-TUH. For additional details, see <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplements 1</xref>–<xref ref-type="fig" rid="fig3s3">3</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary files 3</xref> and <xref ref-type="supplementary-material" rid="supp12">12</xref>. (<bold>C</bold>) The majority of idiopathic infertility cases carrying the <italic>r2/r3</italic> inversion plus secondary <italic>AZFc</italic> partial deletions (total n = 10) exhibit severe oligoasthenoteratozoospermia (OAT) defined as extremely reduced sperm counts (&lt;5 × 10<sup>6</sup>/ml) and concentration (&lt;10 × 10<sup>6</sup>/ejaculate) combined with low fraction of sperms with normal morphology (&lt;4% normal forms) and motility (&lt;32% progressive motile spermatozoa). Reference values for andrological parameters have been applied as referred in (<bold>B</bold>). As total testis volume is mostly within the expected range, their infertility is not caused by intrinsic congenital testicular damage but rather due to severe spermatogenic failure per se. Del, deletion; inv, inversion; dupl, duplication; n, number; sec, secondary; mill, million; ej., ejaculate.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65420-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Distribution of seminal parameters in idiopathic male factor infertility cases with spermatogenic impairment and reference subjects.</title><p>(<bold>A</bold>) Semen volume, (<bold>B</bold>) sperm concentration, (<bold>C</bold>) sperm count and (<bold>D</bold>) progressive motility. Samples are grouped by genotype with the number of samples (n) shown in brackets. del, deletion; sec, secondary; inv, inversion; dupl, duplication; mill, million; ej., ejaculate. Note different scaling of the Y-axis for the two study groups in (<bold>B</bold>) and (<bold>C</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65420-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Distribution of hormonal and testicular parameters in idiopathic male factor infertility cases with spermatogenic impairment and reference individuals.</title><p>(<bold>A</bold>) Total testis volume, (<bold>B</bold>) FSH, (<bold>C</bold>) LH and (<bold>D</bold>) testosterone. Samples are grouped by genotype with the number of samples (n) shown in brackets. Del, deletion; sec, secondary; inv, inversion; dupl, duplication.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65420-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Distribution of andrological parameters in the idiopathic male factor infertility cases (total sperm counts 0–39 × 10<sup>6</sup>) subgrouped based on the structure of the <italic>AZFc</italic> region.</title><p>The median (5–95% range) of each parameter is shown for cases carrying the <italic>r2/r3</italic> inversion plus secondary deletions compared to infertile men without any <italic>AZFc</italic> deletion. The pairwise Wilcoxon rank–sum test was applied to estimate the statistical difference between groups. Statistical significance threshold after correction for multiple testing was estimated p&lt;1.0×10<sup>−3</sup> (a total of 5 tests × 10 independent parameters). Threshold values (shown in blue) for sperm parameters corresponding to severe spermatogenic failure are based on international guidelines (<xref ref-type="bibr" rid="bib51">World Health Organization, 2010</xref>). For reproductive hormones, reference values of the laboratory service provider are shown. The empirical threshold for the total testis volume was based on routinely applied clinical criteria at the AC-TUH. For full details, see <xref ref-type="supplementary-material" rid="supp3">Supplementary files 3</xref> and <xref ref-type="supplementary-material" rid="supp12">12</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65420-fig3-figsupp3-v1.tif"/></fig></fig-group><p>Based on the Y-chromosomal phylogenetic data, one additional patient was identified as an obligate carrier of the <italic>r2/r3</italic> inversion as his Y chromosome represents the lineage R1a1a1b1a1a1c-CTS11962.1 that was also identified in two cases with the <italic>r2/r3</italic> inversion. This patient exhibited signs of unusual deletion and duplication events in the <italic>AZFc</italic> region as he carried six <italic>DAZ</italic>, four <italic>BPY2</italic>, and three copies of the <italic>CDY1</italic> gene (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="supplementary-material" rid="supp9">Supplementary file 9</xref>).</p><p>Among the analyzed 2324 men, 13 cases with the complex <italic>AZFc</italic> rearrangement combining <italic>r2/r3</italic> inversion with a subsequent deletion (from here on referred to as '<italic>r2/r3</italic> inversion plus deletion' for simplicity), represented 0.6% (<xref ref-type="table" rid="table3">Table 3</xref>). Considering the reported population prevalence of R1a1-M458 lineage in Estonians (5.1%; <xref ref-type="bibr" rid="bib49">Underhill et al., 2015</xref>), the estimated number of subjects representing this Y lineage in the study group was ~119. Thus, approximately one in ten chromosomes with the <italic>r2/r3</italic> inversion had undergone a subsequent deletion event (13/119, 11%).</p><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Enrichment of the <italic>AZFc r2/r3</italic> inversion followed by a partial <italic>AZFc</italic> deletion in men with severe spermatogenic failure.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom"/><th valign="bottom"/><th colspan="3" valign="bottom"><italic>AZFc r2/r3</italic> inversion + <italic>AZFc</italic> partial deletion</th></tr><tr><th valign="bottom">Group</th><th valign="bottom">All (n)</th><th valign="bottom">Estimated non-carriers (n)</th><th valign="bottom">Detected carriers (n)</th><th valign="bottom">% of carriers in the (sub)group</th></tr></thead><tbody><tr><td valign="bottom"><italic>a. Full study group</italic></td><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="bottom">All analyzed study subjects</td><td valign="bottom">2324</td><td valign="bottom">2311</td><td valign="bottom">13</td><td valign="bottom">0.6%</td></tr><tr><td valign="bottom">Study subjects with sperm counts</td><td valign="bottom">2000</td><td valign="bottom">1988</td><td valign="bottom">12</td><td valign="bottom">0.6%</td></tr><tr><td colspan="5" valign="bottom"><italic>Subjects stratified based on total sperm counts per ejaculate</italic></td></tr><tr><td valign="bottom">Sperm counts 0–10 × 10<sup>6</sup></td><td valign="bottom">524</td><td valign="bottom">515</td><td valign="bottom">9</td><td valign="bottom">1.7%</td></tr><tr><td valign="bottom">Sperm counts &gt; 10 × 10<sup>6</sup></td><td valign="bottom">1476</td><td valign="bottom">1473</td><td valign="bottom">3</td><td valign="bottom">0.2%</td></tr><tr><td valign="bottom"/><td valign="bottom"/><td colspan="3" valign="bottom">Fisher’s exact test, p=6.0×10<sup>−4</sup>, OR = 8.6 [95% CI 2.3–31.8]</td></tr><tr><td colspan="5" valign="bottom"><italic>b. Carriers of the Y lineage R1a1a-M458*</italic></td></tr><tr><td valign="bottom">In all analyzed study subjects</td><td valign="bottom">119</td><td valign="bottom">106</td><td valign="bottom">13</td><td valign="bottom">11.0%</td></tr><tr><td valign="bottom">In study subjects with sperm counts</td><td valign="bottom">102</td><td valign="bottom">90</td><td valign="bottom">12</td><td valign="bottom">11.8%</td></tr><tr><td colspan="5" valign="bottom"><italic>Subjects stratified based on total sperm counts per ejaculate</italic></td></tr><tr><td valign="bottom">Sperm counts 0–10 × 10<sup>6</sup></td><td valign="bottom">27</td><td valign="bottom">18</td><td valign="bottom">9</td><td valign="bottom">33.7%</td></tr><tr><td valign="bottom">Sperm counts &gt; 10 × 10<sup>6</sup></td><td valign="bottom">75</td><td valign="bottom">72</td><td valign="bottom">3</td><td valign="bottom">4.0%</td></tr><tr><td valign="bottom"/><td valign="bottom"/><td colspan="3" valign="bottom">Fisher’s exact test, p=3.0×10<sup>−4</sup>, OR = 12.0 [95% CI 2.9–48.9]</td></tr></tbody></table><table-wrap-foot><fn><p>*Expected number of Y lineage R1a1-M458 in each subgroup was estimated using the known Estonian population prevalence 5.1% (<xref ref-type="bibr" rid="bib49">Underhill et al., 2015</xref>).</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-6"><title><italic>r2/r3</italic> inversion promotes recurrent deletions that lead to severe oligoasthenoteratozoospermia</title><p>Idiopathic infertility cases carrying the <italic>r2/r3</italic> inversion plus deletion in the <italic>AZFc</italic> region (n = 10) exhibited extremely low sperm counts compared to subjects without any <italic>AZFc</italic> deletions (median 2.0 vs 12.5 × 10<sup>6</sup>/ejaculate; Wilcoxon test, nominal p=0.011) (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplements 1</xref>–<xref ref-type="fig" rid="fig3s3">3</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Nine of 10 men showed severe spermatogenic failure (total sperm counts &lt;10 × 10<sup>6</sup>/ejaculate), either azoospermia (n = 1), cryptozoospermia (n = 3), or severe oligozoospermia (n = 5) (<xref ref-type="supplementary-material" rid="supp11">Supplementary files 11</xref> and <xref ref-type="supplementary-material" rid="supp12">12</xref>). They also showed consistently the poorest sperm concentration (median 1.0 × 10<sup>6</sup>/ml) and progressive motility (13%), as well as the lowest semen volume (2.3 ml) compared to the rest of analyzed infertile men. The data suggests that extreme oligoasthenoteratozoospermia (OAT) observed in these subjects was due to the severely affected process of spermatogenesis, whereas their testicular volume and hormonal profile were within the typical range of male factor infertility cases (<xref ref-type="fig" rid="fig3">Figure 3C</xref>).</p><p>When all the men with andrological data (n = 2000) were stratified based on sperm counts, there was a highly significant enrichment of <italic>r2/r3</italic> inversion plus deletion in men with severe spermatogenic failure (sperm counts 0–10 × 10<sup>6</sup>) compared to the rest (1.7% vs 0.2%, Fisher’s exact test, p=6.0×10<sup>−4</sup>, OR = 8.6 [95% CI 2.3–31.8]; <xref ref-type="table" rid="table3">Table 3</xref>). The estimated number of phenotyped subjects representing the Y haplogroup R1a1-M458 with the fixed <italic>r2/r3</italic> inversion was 102 (based on population prevalence 5.1%; <xref ref-type="bibr" rid="bib49">Underhill et al., 2015</xref>). Among carriers of this Y lineage, 33.7% of men with sperm counts 0–10 × 10<sup>6</sup> (9/27), but only 4.0% with sperm counts of &gt;10 × 10<sup>6</sup> (3/72) had undergone a subsequent <italic>AZFc</italic> partial deletion (Fisher’s exact test, p=3.0×10<sup>−4</sup>, OR = 12.0 [95% CI 2.9–48.9]).</p><p>Only three reference cases carried a Y chromosome with the <italic>r2/r3</italic> inversion plus deletion. At the time of phenotyping, all three subjects were younger (aged 18, 21, and 23 years) than the variant carriers in the idiopathic infertility group (median 32.4, range 26–51 years) (<xref ref-type="supplementary-material" rid="supp12">Supplementary file 12</xref>). The only reference subject with this complex <italic>AZFc</italic> rearrangement, but unaffected sperm analysis was the youngest (18 years). Notably, another reference man (23 years) with andrological data would actually be classified, based on WHO guidelines (<xref ref-type="bibr" rid="bib51">World Health Organization, 2010</xref>), as an oligozoospermia case (sperm concentration 12 × 10<sup>6</sup>/ml vs threshold 15 × 10<sup>6</sup>/ml). Also, his total sperm counts (39.4 × 10<sup>6</sup>/ejaculate) represented a borderline value.</p></sec><sec id="s2-7"><title>Sequence diversity of the retained <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY</italic> genes is extremely low and has no detectable effect on sperm parameters</title><p>The re-sequenced retained <italic>DAZ1-4</italic>, <italic>BPY2</italic>, and <italic>CDY1-2</italic> genes were characterized by extremely low nucleotide variability in all Y-chromosomal lineages and deletion subtypes (<xref ref-type="supplementary-material" rid="supp13">Supplementary file 13</xref>). For 476 samples (<italic>gr/g</italic>r, n = 40; <italic>b2/b3</italic>, n = 436), re-sequenced for the &gt;94 kb region using Illumina MiSeq, a total of 42 variants were identified with median 0.8 variants/kb and maximum two variants per individual. Most of them were previously undescribed (<xref ref-type="bibr" rid="bib12">Giachini et al., 2008</xref>), singletons (<xref ref-type="bibr" rid="bib16">Jobling and Tyler-Smith, 2017</xref>), and/or non-coding SNVs/short indels (<xref ref-type="bibr" rid="bib30">Lu et al., 2011</xref>; <xref ref-type="supplementary-material" rid="supp14">Supplementary file 14</xref>). The <italic>CDY2a-CDY2b</italic> genes harbored only one variable site, whereas <italic>DAZ1-DAZ2</italic> carried 24 or 26 SNVs/indels. Most variants appeared paralogous as both the reference and alternative alleles were identified. Among the four detected missense variants, CDY1b p.T419N was fixed in all three <italic>CDY1b</italic> copies present on the Y chromosome with the <italic>b2/b3</italic> deletion plus <italic>b2/b4</italic> duplications that represented an oligozoospermia case. However, the effect of this conservative substitution is unclear.</p><p>There was thus no evidence that the sequence variation in <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY</italic> genes has any effect on infertility related parameters in the subjects examined.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We conducted a comprehensive investigation of partial deletion subtypes of the Y-chromosomal <italic>AZFc</italic> region in 2324 Estonian men, approximately half with idiopathic spermatogenic impairment (n = 1190) in comparison to the reference group (n = 1134). Importantly, 2000 men had undergone full and uniformly conducted andrological workup at a single clinical center, facilitating fine-scale genotype–phenotype analysis. Previously, no study had undertaken re-sequencing of the retained <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY</italic> genes along with the assessment of the Y haplogroup, dosage, and retained/deleted genes in the <italic>gr/gr</italic> or <italic>b2/b3</italic>-deleted chromosomes in both infertile men and controls. Concordant with the reports from other European populations, the <italic>gr/gr</italic>, but not the <italic>b2/b3</italic> deletion, is a risk factor for spermatogenic impairment in Estonian men with &gt;2-fold increased susceptibility to infertility (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). However, the gathered data on the large group of reference men in the current study demonstrated the existence of Y chromosomes carrying a <italic>gr/gr</italic> deletion without any documented effect on andrological parameters (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). As a novel finding, the study uncovered complex <italic>AZFc</italic> rearrangements within a specific Y haplogroup, R1a1-M458 and its sub-lineages, causing severe spermatogenic failure in the majority of carriers (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="table" rid="table3">Table 3</xref>). This Y lineage has undergone a ~1.6 Mb <italic>r2/r3</italic> inversion in the <italic>AZFc</italic> region that has disrupted the structure of the palindromes P1 and P2, promoting subsequent recurrent deletions and consequently, severely impaired the process of spermatogenesis.</p><p>Consistent with key early observations (<xref ref-type="bibr" rid="bib42">Rozen et al., 2012</xref>; <xref ref-type="bibr" rid="bib22">Krausz et al., 2009</xref>; <xref ref-type="bibr" rid="bib31">Machev, 2004</xref>), this study supports the recurrent nature and high subtype diversity of the <italic>AZFc</italic> partial losses that are currently considered jointly under the umbrella term ‘<italic>gr/gr</italic> deletions’. The 44 detected <italic>gr/gr</italic> deletions in our study sample were estimated to have originated independently at least 26 times across the Y phylogenetic tree and include seven different combinations of <italic>DAZ</italic> and <italic>CDY1</italic> gene losses. Apparently, there is a substantial undescribed heterogeneity in the spread and structure of <italic>gr/gr</italic> deletions that in turn contributes to the phenotypic variability of the genetic effects. Unexpectedly, one in four Estonian <italic>gr/gr</italic> deletion carriers belonged to the Y-chromosomal haplogroup R1a1-M458 (and its sub-lineages) (<xref ref-type="fig" rid="fig2">Figure 2A,B</xref>; 22.7% vs 5.1% reported as the Estonian population frequency; <xref ref-type="bibr" rid="bib49">Underhill et al., 2015</xref>). Notably, a previous study has reported a significant enrichment of the haplogroup R1a (ancestral lineage to the R1a1-M458) among <italic>gr/gr</italic>-deleted chromosomes in the Polish population (<xref ref-type="bibr" rid="bib42">Rozen et al., 2012</xref>), which has a high prevalence, 25%, of R1a1-M458 (<xref ref-type="bibr" rid="bib49">Underhill et al., 2015</xref>; <xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="supplementary-material" rid="supp15">Supplementary file 15</xref>). All the Estonian <italic>gr/gr</italic> cases and also additional <italic>b2/b3</italic> deletion chromosomes representing this Y lineage carried unusual retained <italic>DAZ</italic> gene pairs (<italic>DAZ1-DAZ3</italic> or <italic>DAZ2-DAZ4</italic>) in combination with either <italic>CDY1a</italic> or <italic>CDY1b</italic> gene copy (<xref ref-type="fig" rid="fig2">Figure 2</xref>). These complex <italic>AZFc</italic> rearrangements were best explained by a preceding (and apparently fixed in R1a1-M458) ~1.6 Mb inversion between the homologous <italic>r2</italic> and <italic>r3</italic> amplicons, followed by recurrent secondary partial <italic>AZFc</italic> deletions (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The latter are facilitated by large ampliconic segments positioned in the same orientation. Inversions in the <italic>AZFc</italic> region are not uncommon, but none of the previously described inversions is expected to substantially disrupt the core palindromic structure of the <italic>AZFc</italic> region (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib40">Repping et al., 2004</xref>; <xref ref-type="bibr" rid="bib31">Machev, 2004</xref>). In contrast, the <italic>r2/r3</italic> inversion disrupts the structure of palindrome P1 and expands the size of the P2 palindrome more than twofold (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The critical role of intact P1–P2 palindromes in the <italic>AZFc</italic> structure is supported by the observation that no Y chromosomes have been described with a single <italic>DAZ</italic> gene copy, whereas the inverted <italic>DAZ</italic> gene pairs form the ‘heart’ of both P1 and P2. In future studies, long-read sequencing technologies should be applied to determine the detailed genomic structure of the <italic>AZFc</italic> region in the R1a1-M458 chromosomes and the exact chromosomal breakpoints of the identified <italic>r2/r3</italic> inversion and secondary deletion events in oligozoospermia patients.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>The prevalence of the Y-chromosomal haplogroup R1a1-M458 carrying a fixed <italic>r2/r3</italic> inversion.</title><p>(<bold>A</bold>) Geographical distribution of haplogroup R1a1-M458 and its sub-lineages in Europe. Pie charts indicate populations, with the black sector showing the proportion of R1a1-M458 according to <xref ref-type="bibr" rid="bib49">Underhill et al., 2015</xref>. (<bold>B</bold>) The estimated proportion of subjects among idiopathic cases with severe spermatogenic failure (sperm counts 0–10 × 10<sup>6</sup>/ejaculate) carrying R1a1-M458 Y lineage (and its sub-lineages) chromosomes that have undergone a subsequent partial <italic>AZFc</italic> deletion. The prevalence was estimated using reported population frequencies of R1a1-M458, including Estonians (<xref ref-type="bibr" rid="bib49">Underhill et al., 2015</xref>) and data available in the current study for Estonian men with spermatogenic failure. Estonians are shown in bold and with a striped filling. For full details, see <xref ref-type="supplementary-material" rid="supp15">Supplementary file 15</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65420-fig4-v1.tif"/></fig><p>As a likely scenario, the <italic>r2/r3</italic> inversion plus deletion may predispose to spermatogenic impairment through substantial destabilization of the intra-chromosomal structure affecting meiotic recombination and chromosomal segregation. The removal of some specific genetic factor(s) being responsible for the phenotypic outcome seems a less likely explanation as the <italic>gr/gr</italic> deletion locations are variable, and so far, no reproducible associations with the exact deleted regions or specific gene copies have been identified. However, recent reports have uncovered an abundance of Y-chromosomal non-coding RNAs and their potential functional involvement in spermatogenesis (<xref ref-type="bibr" rid="bib17">Johansson et al., 2019</xref>). The <italic>AZFc</italic> region contains at least one multicopy family of non-coding RNA genes, <italic>TTTY4</italic> (Testis-Specific Transcript, Y-Linked 4) with testis-enriched expression. These genes are located in the three <italic>g1–g3</italic> duplicons flanking the P1 and P2 palindromic ‘hearts’. The phenotypic consequences of <italic>TTTY4</italic> copy number changes are still to be studied. Among 12 Estonian subjects carrying the <italic>AZFc r2/r3</italic> inversion plus deletions and with available data for sperm counts, nine cases exhibited severe spermatogenic failure, two cases had moderate oligozoospermia, and only one case (aged 18 years) was normozoospermic (<xref ref-type="fig" rid="fig3">Figure 3B,C</xref>). This represented ~8- to 9-fold enrichment of this complex rearrangement among men with severely reduced sperm counts (0–10 × 10<sup>6</sup>; <xref ref-type="table" rid="table3">Table 3</xref>). This genetic effect was observed specifically on the effectiveness of spermatogenesis, whereas the measurements of bitesticular volume and reproductive hormone levels did not stand out among the rest of analyzed infertile men. Unfortunately, none of the patients carrying the <italic>r2/r3</italic> inversion plus deletion had undergone a testicular biopsy during their infertility workup. The histopathological pattern of germ cell abnormalities among these cases remains to be investigated in follow-up studies. This knowledge would facilitate understanding of the consequences this Y-chromosomal rearrangement on spermatogenesis and so maximize the benefit of molecular diagnostics in evidence-based clinical management decisions.</p><p>To our knowledge, no other Y-lineage-specific risk variants for spermatogenic impairment have been reported so far. Previously, the <italic>DAZ2–DAZ4</italic> deletion had been shown as a high-risk factor for male infertility in the Tunisian population, but the Y haplogroups of those subjects were not investigated (<xref ref-type="bibr" rid="bib11">Ghorbel et al., 2016</xref>). The survival of such a high-risk lineage in the population seems at first sight surprising, but may be accounted for by its possible age-specific effects on spermatogenesis, which may be exacerbated by the recent general decline in sperm count (<xref ref-type="bibr" rid="bib1">Andersson et al., 2008</xref>). In the past, this lineage may not have been disadvantageous. The possible age-related progressive worsening of the reproductive phenotype among <italic>r2/r3</italic> inversion plus deletion carriers should be investigated in follow-up, ideally longitudinal, studies of sufficiently large numbers of patients to make robust conclusions.</p><p>This study outcome has notable clinical implications for the improvement of molecular diagnostics and reducing the proportion of idiopathic male factor infertility cases. In Northern and Central Europe, the prevalence of R1a1-M458 haplogroup carrying the <italic>r2/r3</italic> inversion ranges from ~1% in the Netherlands and Denmark to ~2–5% in Austria, Hungary, Germany, Baltics, and most Balkan countries, whereas it is widespread in Slavic populations and carried by 12–26% of men (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="supplementary-material" rid="supp15">Supplementary file 15</xref>; <xref ref-type="bibr" rid="bib49">Underhill et al., 2015</xref>). In non-European populations, the R1a1-M458 Y chromosomes are virtually non-existent (for details, see <xref ref-type="bibr" rid="bib49">Underhill et al., 2015</xref>). However, in some European populations, recurrent secondary <italic>AZFc</italic> partial deletions on Y chromosomes representing the R1a1-M458 haplogroup (and its sub-lineages) may potentially explain from 0.3% up to ~9% of cases presenting severe spermatogenic impairment (sperm counts &lt; 10 million per ejaculate) (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Further studies in other populations and large samples of patients and normozoospermic controls are required to fully establish the value of extending the current recommended testing of Y-chromosomal deletions by including the analysis of this novel Y-lineage-specific pathogenic <italic>AZFc</italic> rearrangement.</p><p>The evidence from the literature has shown that the increased prevalence of either <italic>gr/gr</italic> or <italic>b2/b3</italic> deletions in infertility cases appears to be population-dependent (<xref ref-type="bibr" rid="bib3">Bansal et al., 2016a</xref>; <xref ref-type="bibr" rid="bib4">Bansal et al., 2016b</xref>). It can be speculated that also in other populations some specific Y lineages may carry <italic>AZFc</italic> structural variants that in combination with partial deletions (or other rearrangements) predispose to chromosomal instability in the complex process of spermatogenesis involving multiple well-coordinated cell divisions. So far, the largest study of the Y-chromosomal phylogeny of <italic>gr/gr</italic> deletion carriers included 152 infertile subjects representing seven countries with different population genetic structures (<xref ref-type="bibr" rid="bib22">Krausz et al., 2009</xref>). However, the number of cases per population was low and the study included only 17 fertile men. Also, the study did not include fine-scale analysis of Y sub-lineages and the retained gene content. Long-range re-sequencing of the whole <italic>AZFc</italic> region in large numbers of men would be the preferred approach to uncover its structural complexity. Additional pathogenic <italic>AZFc</italic> rearrangements may also exist among Estonian infertile men. Even after omitting the cases carrying a <italic>gr/gr</italic> deletion at the <italic>r2/r3</italic> inversion background, a non-significant enrichment of the remaining <italic>gr/gr</italic> deletion chromosomes can be observed in patients compared to reference men (1.9 vs 1.1%, p&lt;0.1; <xref ref-type="table" rid="table2">Table 2</xref>).</p><p>In addition to the main finding, our deep re-sequencing dataset revealed that neither the dosage, sequence variation, nor exact copy of the retained <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY1</italic> gene showed any detectable effect on spermatogenic parameters. All chromosomes with <italic>AZFc</italic> partial deletions exhibit extremely low overall sequence variation of the retained <italic>DAZ, BPY2</italic>, and <italic>CDY</italic> genes. This observation is consistent with previous reports showing low levels of genetic diversity of the human Y chromosome (<xref ref-type="bibr" rid="bib16">Jobling and Tyler-Smith, 2017</xref>) and suggesting that novel variants may be rapidly removed by active gene conversion among Y-chromosomal duplicate genes or selective constraint (<xref ref-type="bibr" rid="bib14">Hallast et al., 2013</xref>; <xref ref-type="bibr" rid="bib41">Rozen et al., 2003</xref>; <xref ref-type="bibr" rid="bib47">Trombetta and Cruciani, 2017</xref>). Among the re-sequenced 382 chromosomes with <italic>b2/b3</italic> deletions, no pathogenic mutations were detected in the single retained <italic>BPY2</italic> and <italic>CDY1</italic> gene copies. At the same time, the high rates of large structural rearrangements and copy number variation in the Y chromosome are well established, contrasting with low levels of sequence variation (<xref ref-type="bibr" rid="bib46">Teitz et al., 2018</xref>; <xref ref-type="bibr" rid="bib43">Shi et al., 2019</xref>). One in five or six Estonian Y chromosomes with <italic>gr/gr</italic> and <italic>b2/b3</italic> deletions had undergone secondary rearrangements with no apparent effect on tested andrological parameters and fertility potential (<xref ref-type="table" rid="table2">Table 2</xref>). In the literature, the data about the effects of secondary duplications after an initial <italic>AZFc</italic> partial deletion on sperm parameters are inconclusive. Some studies have suggested increased pathogenicity (<xref ref-type="bibr" rid="bib30">Lu et al., 2011</xref>; <xref ref-type="bibr" rid="bib52">Yang et al., 2010</xref>; <xref ref-type="bibr" rid="bib28">Lin et al., 2007</xref>; <xref ref-type="bibr" rid="bib54">Ye et al., 2013</xref>; <xref ref-type="bibr" rid="bib53">Yang et al., 2015</xref>), whereas others have reported neutral or even positive effects on spermatogenesis (<xref ref-type="bibr" rid="bib22">Krausz et al., 2009</xref>; <xref ref-type="bibr" rid="bib12">Giachini et al., 2008</xref>; <xref ref-type="bibr" rid="bib29">Lo Giacco et al., 2014</xref>; <xref ref-type="bibr" rid="bib34">Noordam et al., 2011</xref>). However, further copy number reductions in this genomic region appear to be very rare – none of the 44 <italic>gr/gr</italic> or 631 <italic>b2/b3</italic> deletion carriers were identified with further reductions beyond what is expected from the initial deletion.</p><p>The current study is the largest and most detailed to date in terms of both the number of patients with spermatogenic impairment and reference samples with available andrological data from a single population, and detailed characterization of the genetic diversity of the <italic>AZFc</italic> region and phylogenetic background of the Y chromosomes. Yet, the total number of identified cases with the <italic>r2/r3</italic> inversion followed by a deletion was relatively small and also inadequate to reach the statistical power in association testing with andrological parameters. Follow-up replication studies utilizing sample cohorts from populations with high(er) R1a1-M458 frequency (e.g. Polish, Czech) should be undertaken to confirm the prevalence and significance of the identified risk variant. The biggest challenge of such studies is the availability of sufficiently large sample collections of both patients and reference cases with andrological data. The identification of men with R1a1-M458 Y chromosomes and characterization of subsequent deletion subtypes only require standard inexpensive laboratory techniques such as PCR, restriction fragment length polymorphism (RFLP) analysis, and Sanger sequencing.</p><p>In summary, we have undertaken a comprehensive study of the carriers of <italic>AZFc</italic> partial <italic>gr/gr</italic> and <italic>b2/b3</italic> deletions and uncovered high levels of structural variation in the <italic>AZFc</italic> locus, but low sequence diversity of the coding genes within the region. As a major finding, we discovered a large inversion specific to the Y lineage R1a1-M458 that represents a hotspot for subsequent <italic>AZFc</italic> partial deletions. Men carrying Y chromosomes with this complex rearrangement have &gt;10 fold increased risk of severe spermatogenic failure, but the consequences of this risk could potentially be alleviated by early identification of the variant carriers and facilitating the storage of their sperm samples. Our study results thus have the potential to improve clinical diagnostics and management of idiopathic impaired spermatogenesis in a significant fraction of men originating from Northern and Central European populations.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Study subjects</title><p>Patients with idiopathic spermatogenic impairment (n = 1190) were recruited at the Andrology Centre at Tartu University Hospital (AC-TUH) in 2003–2015 (PI: M. Punab). Included cases showed reduced sperm counts (&lt;39 × 10<sup>6</sup>/ejaculate) in at least two consecutive semen analyses (<xref ref-type="bibr" rid="bib51">World Health Organization, 2010</xref>). Recruitment and sampling, semen analyses, hormone assays, and definition of idiopathic cases have previously been described in detail (<xref ref-type="bibr" rid="bib37">Punab et al., 2017</xref>). Men with known causes of male infertility detected during routine diagnostic workup were excluded, for example cryptorchidism, testicular cancer, orchitis/epididymitis, mumps orchitis, testis trauma, karyotype abnormalities, and complete Y-chromosomal microdeletions. The final idiopathic infertility group included 104 azoospermia (no sperm), 88 cryptozoospermia (sperm counts &gt; 0–1 × 10<sup>6</sup>/ejaculate), 319 severe oligozoospermia (1–10 × 10<sup>6</sup>), and 679 moderate oligozoospermia (10–38 × 10<sup>6</sup>) cases (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><p>The reference sample of Estonian men (n = 1134) comprised healthy young men (n = 499) and subjects with proven fatherhood (n = 635) (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). The cohort of ‘Estonian young men’ (n = 499) was recruited at the AC-TUH in 2003–2004 (PI: M. Punab), representing a healthy male group with median age 18.6 (17.2–22.9) years at the time of recruitment (<xref ref-type="bibr" rid="bib13">Grigorova et al., 2008</xref>). The subgroup of ‘Partners of pregnant women’ (n = 324) includes male partners of pregnant women, recruited in 2010–2014 at the Tartu University Hospital and the West Tallinn Central Hospital (<xref ref-type="bibr" rid="bib37">Punab et al., 2017</xref>). Eight hundered and ten men (of 823) in these subgroups underwent sperm analysis.</p><p>The subgroup of ‘REPROMETA proven fathers’ (n = 311) was recruited in 2006–2011 at the Women's Clinic at Tartu University Hospital during the REPROMETA study (PI: M. Laan), originally designed to collect mother–father–placenta trios at delivery to investigate genetics of pregnancy complications (<xref ref-type="bibr" rid="bib20">Kikas et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Pilvar et al., 2019</xref>). In this study, the REPROMETA fathers represented reference men with proven fertility. Only self-reported age and body mass index (BMI) data were available for this subgroup.</p><p>All men, who had turned to Andrology Centre, Tartu University Hospital (AC-TUH) due to idiopathic infertility (n = 1190), as well as the participants of the 'Estonian young men' cohort (n = 499) and the subgroup ‘Partners of pregnant women' (n = 324) were offered complete routine andrological workup. The subjects were examined by specialist andrologists at the AC-TUH, who had received respective training in clinical assessment and standardized andrological workup, locally and in collaboration with other European Andrology Academy (EAA)-accredited centers. Also, anthropometric parameters were documented during clinical examination. Details are described in <xref ref-type="bibr" rid="bib37">Punab et al., 2017</xref>.</p><p>Physical examination for the assessment of genital pathology and testicular size (orchidometer; made of birch wood, Pharmacia and Upjohn, Denmark) was performed with the patients in standing position. The total testis volume is the sum of right and left testicles. The position of the testicles in the scrotum, pathologies of the genital ducts (epididymitis and ductus deference), and the penis, urethra, presence, and, if applicable, grade of varicocele were registered for each subject.</p><p>For 2000 study subjects, sperm analysis was performed, whereas 13 reference cases did not agree with this procedure. Semen samples were obtained by patient masturbation, and semen analysis was performed in accordance with the World Health Organization (WHO) recommendations. In brief, after ejaculation, the semen was incubated at 37°C for 30–40 min for liquefaction. Semen volume was estimated by weighing the collection tube with the semen sample and subsequently subtracting the predetermined weight of the empty tube assuming 1 g = 1 ml. For assessment of the spermatozoa concentration, the samples were diluted in a solution of 0.6 mol/l NaHCO3% and 0.4% (v/v) formaldehyde in distilled water. The spermatozoa concentration was assessed using the improved Neubauer haemocytometers.</p><p>Genomic DNA was extracted from EDTA-blood. After blood draw in the morning, serum and plasma fractions were separated immediately for hormone measurements (FSH, LH, testosterone). All laboratory analyses and routine genetic testing (karyotyping, Y-chromosomal microdeletions) were performed at the United Laboratories of Tartu University Hospital according to the established clinical laboratory guidelines. Detailed methodology and reference values for hormonal levels are available by the service provider: <ext-link ext-link-type="uri" xlink:href="https://www.kliinikum.ee/">https://www.kliinikum.ee/</ext-link>yhendlabor/analueueside-taehestikuline-register.</p></sec><sec id="s4-2"><title>Genotyping Y-chromosomal microdeletions</title><p>All study subjects (n = 2324) were typed for complete <italic>AZFa</italic> (loss of markers sY84 and sY86), <italic>AZFb</italic> (sY127 and sY134), <italic>AZFc</italic> (sY254 and sY255), and partial <italic>AZFc</italic> deletions <italic>gr/gr</italic> (sY1291), <italic>b2/b3</italic> (sY1191), and <italic>b1/b3</italic> (sY1161, sY1191, and sY1291) following established PCR primers (<xref ref-type="bibr" rid="bib23">Krausz et al., 2014</xref>; <xref ref-type="bibr" rid="bib27">Lin et al., 2006</xref>; <xref ref-type="supplementary-material" rid="supp16">Supplementary file 16</xref>). The multiplex PCR contained the final concentrations of 1× PCR buffer B1 (Solis Biodyne, Estonia), 2.5 mM MgCl<sub>2</sub>, 2.5 mM dNTP, 2 µM PCR primers for STS markers sY1291 and sY1201, 3 µM PCR primers for STS markers sY1191, sY1206, and sY1161 (<xref ref-type="supplementary-material" rid="supp16">Supplementary file 16</xref>), 1U FIREPol DNA polymerase (Solis Biodyne), and 10 ng of template genomic DNA per reaction. The following PCR conditions were used: for 5 min at 95°C, followed by 32 cycles of 30 s at 95°C, 30 s at 63°C and 1 min at 72°C, final extension of 10 min at 72°C and a 4°C hold. The presence/absence of PCR products in a reaction were checked on 2% agarose gel. Lack of amplification of STS marker sY1291 (but presence of all others) was used to determine the <italic>gr/gr</italic> deletion and lack of sY1191 the <italic>b2/b3</italic> deletion.</p></sec><sec id="s4-3"><title>Re-sequencing of retained <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY</italic> genes using Illumina MiSeq</title><p>Re-sequencing of the exonic regions of the retained <italic>AZFc</italic> genes (according to Ensembl release 84, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002344">SCR_002344</ext-link>) in 476 cases with either <italic>gr/gr</italic> or <italic>b2/b3</italic> deletions targeted in total 94,188 bp per subject. <italic>CDY, BPY2</italic>, and <italic>DAZ</italic> genes were amplified using 8, 10, or 26 PCR primer pairs, respectively (<xref ref-type="supplementary-material" rid="supp17">Supplementary files 17</xref> and <xref ref-type="supplementary-material" rid="supp18">18</xref>). The presence of all amplicons was confirmed using gel electrophoresis. Amplicons were pooled in equimolar concentrations, barcoded per sample, and sequenced (250 bp reads, paired-end) on Illumina MiSeq (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016379">SCR_016379</ext-link>) with at least 40× coverage. BWA (v0.7.15, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_010910">SCR_010910</ext-link>) (<xref ref-type="bibr" rid="bib26">Li and Durbin, 2009</xref>) was implemented to map the sequencing reads to a modified human genome reference (GRChg38), where <italic>CDY1a</italic>, <italic>CDY2a</italic>, <italic>BPY2a</italic> and either <italic>DAZ3-DAZ4</italic> (<italic>gr/gr</italic> carriers) or <italic>DAZ1-DAZ2</italic> (<italic>b2/b3</italic> carriers) remained unchanged, but the sequences of other <italic>CDY</italic>, <italic>BPY2</italic>, and <italic>DAZ</italic> gene copies were replaced with 'Ns'. SNVs and indels were identified using GATK HaplotypeCaller (v3.7, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001876">SCR_001876</ext-link>), with a minimum base quality 20 and outputting all sites (<xref ref-type="bibr" rid="bib32">McKenna et al., 2010</xref>). Y-chromosomal phylogenetic markers were called using bcftools (v1.8, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_005227">SCR_005227</ext-link>), with minimum base quality 20, mapping quality 20 and defining ploidy as 1.</p><p>Re-sequencing included 31 patients and nine reference men with <italic>AZFc gr/gr</italic> deletions. Six men carrying <italic>gr/gr</italic> deletions were not analyzed due to DNA limitations (two cases) or unavailable andrological data (four cases). The analysis of <italic>b2/b3</italic> deletion carriers included 382 patients (haplogroup N3: n = 380; non-N3, n = 2) and 54 'Partners of pregnant women’ (N3: n = 53; non-N3, n = 1).</p></sec><sec id="s4-4"><title>Analysis of variant effects from the illumina MiSeq dataset</title><p>Variant effect prediction was performed using the Variant Effect Predictor tool (VEP, <ext-link ext-link-type="uri" xlink:href="https://www.ensembl.org/Tools/VEP">https://www.ensembl.org/Tools/VEP</ext-link>, Ensembl release 99, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_007931">SCR_007931</ext-link>) (<xref ref-type="bibr" rid="bib33">McLaren et al., 2016</xref>). The Combined Annotation Dependent Depletion (CADD) score ≥ 20, that is, including variants among the top 1% of deleterious variants in the human genome, was considered indicative of potential functional importance of identified SNVs in the coding regions (<xref ref-type="bibr" rid="bib38">Rentzsch et al., 2019</xref>).</p></sec><sec id="s4-5"><title>Y-chromosomal haplogroup typing</title><p>Y lineages of the <italic>gr/gr</italic> samples were defined using 14 markers included in the re-sequencing, plus 34 additional markers determined by Sanger sequencing or restriction fragment length polymorphism (RFLP) analysis (<xref ref-type="supplementary-material" rid="supp18">Supplementary files 18</xref> and <xref ref-type="supplementary-material" rid="supp19">19</xref>). The <italic>b2/b3</italic>-deletion carriers were typed for Y marker N3-M46 (Tat) (<xref ref-type="bibr" rid="bib55">Zerjal et al., 1997</xref>). The sub-lineages of the re-sequenced haplogroup N3 samples were defined in more detail using 16 phylogenetic markers from the Illumina MiSeq dataset, following established nomenclature (<xref ref-type="bibr" rid="bib15">Ilumäe et al., 2016</xref>; <xref ref-type="bibr" rid="bib19">Karmin et al., 2015</xref>). For the other haplogroups, nomenclature according to the International Society of Genetic Genealogy (ISOGG, version 14.14) was followed.</p><p>The R1a1a1b1a1a-lineage-specific phylogenetic marker M458 (rs375323198, A &gt; G polymorphism, GRCh38 genomic coordinate: chrY: 22220317), indicating the carrier status of <italic>r2/r3</italic> inverted Y chromosome was amplified using the following conditions: PCR contained the final concentrations of 1× PCR buffer B1 (Solis Biodyne), 2.5 mM MgCl<sub>2</sub>, 2.5 mM dNTP, 10 µM forward and reverse PCR primers for M458 (see <xref ref-type="supplementary-material" rid="supp19">Supplementary file 19</xref> for primer sequences), 1U FIREPol DNA polymerase (Solis Biodyne OÜ), and 10 ng of template genomic DNA per reaction. The following PCR conditions were used: for 5 min at 95°C, followed by 32 cycles of 30 s at 95°C, 30 s at 52°C and 1 min at 72°C, final extension of 10 min at 72°C and a 4°C hold. The presence of the M458 marker in derived state (instead of the ancestral allele ‘A’ presence of allele ‘G’ at position 147) was determined using Sanger sequencing.</p></sec><sec id="s4-6"><title>Determination of <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY</italic> gene dosage and gene types</title><p>The Bio-Rad QX 200 Droplet Digital PCR system (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_019707">SCR_019707</ext-link>) was used to quantify the copy numbers of the retained <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY</italic> genes for 44 <italic>gr/gr</italic> deletion carriers (31 cases, 13 reference men with sperm analysis data) and 631 <italic>b2/b3</italic> carriers (382 cases/249 reference men) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). The PCR primers and probes were designed using Primer3plus (version 2.4.2, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003081">SCR_003081</ext-link>), PCR were performed according to the recommendations in the Droplet Digital PCR Application Guide (Bio-Rad, U.S.) (<xref ref-type="supplementary-material" rid="supp20">Supplementary file 20</xref>) and described in <xref ref-type="bibr" rid="bib43">Shi et al., 2019</xref>. A XQ200 Droplet Reader was used to measure the fluorescence of each droplet and QuantaSoft software (v1.6.6.0320; Bio-Rad) to cluster droplets into distinct fluorescent groups. The copy number of each gene was determined by calculating the ratio of target (unknown – <italic>DAZ</italic>, <italic>BPY2</italic>, or <italic>CDY</italic>) and reference (single-copy <italic>SRY</italic> gene) concentration. ddPCR for each gene were performed once for every sample. For samples carrying the <italic>gr/gr</italic> deletion, if the copy number obtained differed from the expected (two copies of <italic>DAZ</italic> and <italic>BPY2</italic>, three copies of <italic>CDY</italic>), then the ddPCR reaction was repeated. For <italic>b2/b3</italic> carriers, typing was repeated for all samples not carrying the two most typical copy numbers (2-1-3 or 4-2-4 copies of <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY</italic> genes, respectively). Additionally, a total of 5% of random samples were replicated. If the copy number estimates between replicates differed by 0.8 or more, then a third replicate was performed, and the final copy number was calculated as average of the two closest replicates.</p><p>The re-sequencing data of the <italic>DAZ</italic> genes covered nine paralogous sequence variants that were used to determine the retained gene copies in the <italic>gr/gr</italic> and <italic>b2/b3</italic> deletion carriers (<xref ref-type="supplementary-material" rid="supp21">Supplementary file 21</xref>). For the validation of the <italic>DAZ</italic> gene copy mapping approach, at least five <italic>gr/gr</italic> carriers were additionally typed for published SNV combinations differentiating the <italic>DAZ</italic> gene copies (<xref ref-type="bibr" rid="bib31">Machev, 2004</xref>; <xref ref-type="bibr" rid="bib9">Fernandes et al., 2002</xref>). The retained <italic>CDY1</italic> gene was identified according to <xref ref-type="bibr" rid="bib31">Machev, 2004</xref>.</p></sec><sec id="s4-7"><title>Genetic association testing with andrological parameters</title><p>Statistical testing for the associations between <italic>AZFc gr/gr</italic> or <italic>b2/b3</italic> deletions and andrological parameters was conducted using RStudio (version 1.2.1335, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_000432">SCR_000432</ext-link>), and data were visualised using ggplot2 (version 3.2.1, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014601">SCR_014601</ext-link>) (<xref ref-type="bibr" rid="bib50">Wickham, 2009</xref>). Differences in continuous clinical variables between groups were compared using the non-parametric pairwise Wilcoxon rank-sum test.</p><p>Genetic association with the carrier status of <italic>b2/b3</italic> deletion and its subtypes was also tested using linear regression analyses adjusted for age. For sperm parameters abstinence time and for total testosterone levels, BMI estimates were additionally used as cofactors. Natural log transformation was used to achieve an approximately normal distribution of values. In all cases (except total sperm counts), the applied transformation resulted in a close-to-normal distribution of values. For the linear regression analyses, statistical significance threshold after correction for multiple testing was estimated p&lt;1.0×10<sup>−3</sup> (six tests × eight independent parameters).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank all the patients for making this study possible. The clinical team at the Andrology Centre, Tartu University Hospital is thanked for the professional phenotyping and assistance in patient recruitment over many years. Mart Adler and Eve Laasik are specifically acknowledged for the management of the Androgenetics Biobank, and all ML team members are thanked for their contributions to the DNA extractions. Our work was supported by the Wellcome Trust (098051). This work was supported by Estonian Research Council Grants PUT1036 (PH and LK), PUT181 (MP, KP, and OP), IUT34-12 (LK, MG, KR, and ML), PRG1021 (MP, KR, and ML), IUT24-1 (RF and SR), and MOBTT53 (SR). Establishment of the cohort of Estonian infertility subjects was also supported by the EU through the European Regional Development Fund, project HAPPY PREGNANCY, no. 3.2.0701.12–004 (ML, MP, and KR).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Validation, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources, Data curation, Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Data curation, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Data curation, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Data curation, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Resources, Data curation, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Resources, Data curation, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Resources, Data curation, Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Resources, Data curation, Writing - review and editing</p></fn><fn fn-type="con" id="con13"><p>Resources, Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con14"><p>Resources, Supervision, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con15"><p>Resources, Formal analysis, Supervision, Funding acquisition, Investigation, Writing - original draft, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The study was approved by the Ethics Review Committee on Human Research of the University of Tartu, Estonia (permissions 146/18, 152/4, 221/T-6, 221/M-5, 272/M-13, 267M-13, 286M-18, 288M-13), and sequencing/genotyping was approved at the Wellcome Sanger Institute under WTSI HMDMC 17/105. Written informed consent for evaluation and use of their clinical data for scientific purposes was obtained from each person prior to recruitment. All procedures and methods have been carried out in compliance with the guidelines of the Declaration of Helsinki.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Characteristics of the Estonian patients with idiopathic spermatogenic impairment and the used reference groups showing mean and standard deviation values.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp1-v1.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Frequencies of <italic>AZFc</italic> partial deletions identified in patients and reference groups.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp2-v1.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Andrological parameters of patients and reference cases with and without the <italic>AZFc</italic> rearrangements.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp3-v1.xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Genetic association test with the carrier status of <italic>AZFc b2/b3</italic> deletion results using linear regression.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp4-v1.xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Y haplogroup distribution and enrichment of lineage R1a1a1b1a1a-M458 among Estonian patients and reference cases carrying the gr/gr deletions.</title><p>(a) Y haplogroup distribution of the Estonian patients with idiopathic spermatogenic impairment and reference cases carrying <italic>gr/gr</italic> deletions.</p><p>(b) Enrichment of Y-chromosomal lineage R1a1a1b1a1a-M458 in men carrying <italic>gr/gr</italic> deletion.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp5-v1.xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Y haplogroup distribution of the Estonian patients with idiopathic spermatogenic impairment and reference cases with Y chromosomes having lost the <italic>b2/b3</italic> deletion marker sY1191.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp6-v1.xlsx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>Retained <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY1</italic> copy numbers on the Y chromosomes with either <italic>gr/gr</italic> deletion or having lost the <italic>b2/b3</italic> deletion marker sY1191.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp7-v1.xlsx"/></supplementary-material><supplementary-material id="supp8"><label>Supplementary file 8.</label><caption><title>Retained <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY1</italic> copy numbers on the Y chromosomes with either <italic>gr/gr</italic> deletion or having lost the <italic>b2/b3</italic> deletion marker sY1191.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp8-v1.xlsx"/></supplementary-material><supplementary-material id="supp9"><label>Supplementary file 9.</label><caption><title>Retained <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY1</italic> copy numbers according to Y lineage in samples having lost the <italic>b2/b3</italic> deletion marker sY1191.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp9-v1.xlsx"/></supplementary-material><supplementary-material id="supp10"><label>Supplementary file 10.</label><caption><title>Deleted <italic>DAZ</italic> and <italic>CDY1</italic> gene types in <italic>gr/gr</italic> and <italic>b2/b3</italic> carriers.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp10-v1.xlsx"/></supplementary-material><supplementary-material id="supp11"><label>Supplementary file 11.</label><caption><title>Detailed copy number, deletion type, and Y haplogroup information for samples carrying the <italic>gr/gr</italic> deletion.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp11-v1.xlsx"/></supplementary-material><supplementary-material id="supp12"><label>Supplementary file 12.</label><caption><title>Andrological parameters of 10 patients and two reference cases with ‘<italic>r2/r3</italic>’ inversion plus <italic>gr/gr, b2/b3</italic>, or complex deletion.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp12-v1.xlsx"/></supplementary-material><supplementary-material id="supp13"><label>Supplementary file 13.</label><caption><title>Summary of genetic variation identified on the Y chromosomes with <italic>AZFc</italic> region rearrangements (n = 476).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp13-v1.xlsx"/></supplementary-material><supplementary-material id="supp14"><label>Supplementary file 14.</label><caption><title>Identified SNVs and indels from re-sequencing of retained <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY</italic> genes on the Y chromosomes with <italic>AZFc</italic> region rearrangements.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp14-v1.xlsx"/></supplementary-material><supplementary-material id="supp15"><label>Supplementary file 15.</label><caption><title>Population frequencies of R1a1a1b1a1a-M458 Y lineage and expected proportion of cases with the complex rearrangement <italic>r2/r3</italic> inversion + secondary rearrangement among men with sperm counts of &lt;10 mill/ejaculate.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp15-v1.xlsx"/></supplementary-material><supplementary-material id="supp16"><label>Supplementary file 16.</label><caption><title>Y-chromosomal STS markers and PCR primers used for detection of partial <italic>AZFc</italic> deletions.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp16-v1.xlsx"/></supplementary-material><supplementary-material id="supp17"><label>Supplementary file 17.</label><caption><title>Genomic coordinates of regions sequenced using Illumina MiSeq.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp17-v1.xlsx"/></supplementary-material><supplementary-material id="supp18"><label>Supplementary file 18.</label><caption><title>PCR primers and reaction conditions to amplify regions of interest for sequencing with Illumina MiSeq.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp18-v1.xlsx"/></supplementary-material><supplementary-material id="supp19"><label>Supplementary file 19.</label><caption><title>PCR primers used for typing of Y phylogenetic markers.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp19-v1.xlsx"/></supplementary-material><supplementary-material id="supp20"><label>Supplementary file 20.</label><caption><title>PCR primers and probes used for copy number detection of <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY</italic> genes using droplet digital PCR.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp20-v1.xlsx"/></supplementary-material><supplementary-material id="supp21"><label>Supplementary file 21.</label><caption><title>Paralogous sequence variants used to determine the retained <italic>DAZ</italic> and <italic>CDY1</italic> genes.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65420-supp21-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-65420-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Illumina MiSeq re-sequencing data are available through the European Genome-phenome Archive (EGA, <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/">https://www.ebi.ac.uk/</ext-link>) under the accession number: EGAS00001002157.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Hallast</surname><given-names>P</given-names></name><name><surname>Kibena</surname><given-names>L</given-names></name><name><surname>Punab</surname><given-names>M</given-names></name><name><surname>Laan</surname><given-names>M</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Tyler-Smith</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Resequencing candidate genes for male spermatogenic impairment</data-title><source>EGA</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://ega-archive.org/datasets/EGAD00001006784">EGAS00001002157</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname> <given-names>AM</given-names></name><name><surname>Jørgensen</surname> <given-names>N</given-names></name><name><surname>Main</surname> <given-names>KM</given-names></name><name><surname>Toppari</surname> <given-names>J</given-names></name><name><surname>Rajpert-De Meyts</surname> <given-names>E</given-names></name><name><surname>Leffers</surname> <given-names>H</given-names></name><name><surname>Juul</surname> <given-names>A</given-names></name><name><surname>Jensen</surname> <given-names>TK</given-names></name><name><surname>Skakkebaek</surname> <given-names>NE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Adverse trends in male reproductive health: we may have reached a crucial 'tipping point'</article-title><source>International Journal of Andrology</source><volume>31</volume><fpage>74</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2605.2007.00853.x</pub-id><pub-id pub-id-type="pmid">18194282</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>ASRM</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Diagnostic evaluation of the infertile male: a committee opinion</article-title><source>Fertility and Sterility</source><volume>103</volume><fpage>e18</fpage><lpage>e25</lpage><pub-id pub-id-type="doi">10.1016/j.fertnstert.2014.12.103</pub-id><pub-id pub-id-type="pmid">25597249</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bansal</surname> <given-names>SK</given-names></name><name><surname>Jaiswal</surname> <given-names>D</given-names></name><name><surname>Gupta</surname> <given-names>N</given-names></name><name><surname>Singh</surname> <given-names>K</given-names></name><name><surname>Dada</surname> <given-names>R</given-names></name><name><surname>Sankhwar</surname> <given-names>SN</given-names></name><name><surname>Gupta</surname> <given-names>G</given-names></name><name><surname>Rajender</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Gr/gr deletions on Y-chromosome correlate with male infertility: an original study, meta-analyses, and trial sequential analyses</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>19798</elocation-id><pub-id pub-id-type="doi">10.1038/srep19798</pub-id><pub-id pub-id-type="pmid">26876364</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bansal</surname> <given-names>SK</given-names></name><name><surname>Gupta</surname> <given-names>G</given-names></name><name><surname>Rajender</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Y chromosome b2/b3 deletions and male infertility: a comprehensive meta-analysis, trial sequential analysis and systematic review</article-title><source>Mutation Research/Reviews in Mutation Research</source><volume>768</volume><fpage>78</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.mrrev.2016.04.007</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colaco</surname> <given-names>S</given-names></name><name><surname>Modi</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetics of the human Y chromosome and its association with male infertility</article-title><source>Reproductive Biology and Endocrinology</source><volume>16</volume><elocation-id>14</elocation-id><pub-id pub-id-type="doi">10.1186/s12958-018-0330-5</pub-id><pub-id pub-id-type="pmid">29454353</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname> <given-names>RL</given-names></name><name><surname>Brand</surname> <given-names>H</given-names></name><name><surname>Karczewski</surname> <given-names>KJ</given-names></name><name><surname>Zhao</surname> <given-names>X</given-names></name><name><surname>Alföldi</surname> <given-names>J</given-names></name><name><surname>Francioli</surname> <given-names>LC</given-names></name><name><surname>Khera</surname> <given-names>AV</given-names></name><name><surname>Lowther</surname> <given-names>C</given-names></name><name><surname>Gauthier</surname> <given-names>LD</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Watts</surname> <given-names>NA</given-names></name><name><surname>Solomonson</surname> <given-names>M</given-names></name><name><surname>O'Donnell-Luria</surname> <given-names>A</given-names></name><name><surname>Baumann</surname> <given-names>A</given-names></name><name><surname>Munshi</surname> <given-names>R</given-names></name><name><surname>Walker</surname> <given-names>M</given-names></name><name><surname>Whelan</surname> <given-names>CW</given-names></name><name><surname>Huang</surname> <given-names>Y</given-names></name><name><surname>Brookings</surname> <given-names>T</given-names></name><name><surname>Sharpe</surname> <given-names>T</given-names></name><name><surname>Stone</surname> <given-names>MR</given-names></name><name><surname>Valkanas</surname> <given-names>E</given-names></name><name><surname>Fu</surname> <given-names>J</given-names></name><name><surname>Tiao</surname> <given-names>G</given-names></name><name><surname>Laricchia</surname> <given-names>KM</given-names></name><name><surname>Ruano-Rubio</surname> <given-names>V</given-names></name><name><surname>Stevens</surname> <given-names>C</given-names></name><name><surname>Gupta</surname> <given-names>N</given-names></name><name><surname>Cusick</surname> <given-names>C</given-names></name><name><surname>Margolin</surname> <given-names>L</given-names></name><name><surname>Taylor</surname> <given-names>KD</given-names></name><name><surname>Lin</surname> <given-names>HJ</given-names></name><name><surname>Rich</surname> <given-names>SS</given-names></name><name><surname>Post</surname> <given-names>WS</given-names></name><name><surname>Chen</surname> <given-names>YI</given-names></name><name><surname>Rotter</surname> <given-names>JI</given-names></name><name><surname>Nusbaum</surname> <given-names>C</given-names></name><name><surname>Philippakis</surname> <given-names>A</given-names></name><name><surname>Lander</surname> <given-names>E</given-names></name><name><surname>Gabriel</surname> <given-names>S</given-names></name><name><surname>Neale</surname> <given-names>BM</given-names></name><name><surname>Kathiresan</surname> <given-names>S</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Banks</surname> <given-names>E</given-names></name><name><surname>MacArthur</surname> <given-names>DG</given-names></name><name><surname>Talkowski</surname> <given-names>ME</given-names></name><collab>Genome Aggregation Database Production Team</collab><collab>Genome Aggregation Database Consortium</collab></person-group><year iso-8601-date="2020">2020</year><article-title>A structural variation reference for medical and population genetics</article-title><source>Nature</source><volume>581</volume><fpage>444</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2287-8</pub-id><pub-id pub-id-type="pmid">32461652</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datta</surname> <given-names>J</given-names></name><name><surname>Palmer</surname> <given-names>MJ</given-names></name><name><surname>Tanton</surname> <given-names>C</given-names></name><name><surname>Gibson</surname> <given-names>LJ</given-names></name><name><surname>Jones</surname> <given-names>KG</given-names></name><name><surname>Macdowall</surname> <given-names>W</given-names></name><name><surname>Glasier</surname> <given-names>A</given-names></name><name><surname>Sonnenberg</surname> <given-names>P</given-names></name><name><surname>Field</surname> <given-names>N</given-names></name><name><surname>Mercer</surname> <given-names>CH</given-names></name><name><surname>Johnson</surname> <given-names>AM</given-names></name><name><surname>Wellings</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Prevalence of infertility and help seeking among 15 000 women and men</article-title><source>Human Reproduction</source><volume>31</volume><fpage>2108</fpage><lpage>2118</lpage><pub-id pub-id-type="doi">10.1093/humrep/dew123</pub-id><pub-id pub-id-type="pmid">27365525</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Carvalho</surname> <given-names>CMB</given-names></name><name><surname>Zuccherato</surname> <given-names>LW</given-names></name><name><surname>Fujisawa</surname> <given-names>M</given-names></name><name><surname>Shirakawa</surname> <given-names>T</given-names></name><name><surname>Ribeiro-Dos-Santos</surname> <given-names>AKC</given-names></name><name><surname>Santos</surname> <given-names>SEB</given-names></name><name><surname>Pena</surname> <given-names>SDJ</given-names></name><name><surname>Santos</surname> <given-names>FR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Study of AZFc partial deletion gr/gr in fertile and infertile japanese males</article-title><source>Journal of Human Genetics</source><volume>51</volume><fpage>794</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1007/s10038-006-0024-2</pub-id><pub-id pub-id-type="pmid">16900294</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname> <given-names>S</given-names></name><name><surname>Huellen</surname> <given-names>K</given-names></name><name><surname>Goncalves</surname> <given-names>J</given-names></name><name><surname>Dukal</surname> <given-names>H</given-names></name><name><surname>Zeisler</surname> <given-names>J</given-names></name><name><surname>Rajpert De Meyts</surname> <given-names>E</given-names></name><name><surname>Skakkebaek</surname> <given-names>NE</given-names></name><name><surname>Habermann</surname> <given-names>B</given-names></name><name><surname>Krause</surname> <given-names>W</given-names></name><name><surname>Sousa</surname> <given-names>M</given-names></name><name><surname>Barros</surname> <given-names>A</given-names></name><name><surname>Vogt</surname> <given-names>PH</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia</article-title><source>Molecular Human Reproduction</source><volume>8</volume><fpage>286</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1093/molehr/8.3.286</pub-id><pub-id pub-id-type="pmid">11870237</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname> <given-names>S</given-names></name><name><surname>Paracchini</surname> <given-names>S</given-names></name><name><surname>Meyer</surname> <given-names>LH</given-names></name><name><surname>Floridia</surname> <given-names>G</given-names></name><name><surname>Tyler-Smith</surname> <given-names>C</given-names></name><name><surname>Vogt</surname> <given-names>PH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A large AZFc deletion removes DAZ3/DAZ4 and nearby genes from men in Y haplogroup N</article-title><source>The American Journal of Human Genetics</source><volume>74</volume><fpage>180</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1086/381132</pub-id><pub-id pub-id-type="pmid">14639527</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghorbel</surname> <given-names>M</given-names></name><name><surname>Baklouti-Gargouri</surname> <given-names>S</given-names></name><name><surname>Keskes</surname> <given-names>R</given-names></name><name><surname>Chakroun</surname> <given-names>N</given-names></name><name><surname>Sellami</surname> <given-names>A</given-names></name><name><surname>Fakhfakh</surname> <given-names>F</given-names></name><name><surname>Ammar-Keskes</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Gr/gr-DAZ2-DAZ4-CDY1b deletion is a high-risk factor for male infertility in tunisian population</article-title><source>Gene</source><volume>592</volume><fpage>29</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2016.07.050</pub-id><pub-id pub-id-type="pmid">27457284</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giachini</surname> <given-names>C</given-names></name><name><surname>Laface</surname> <given-names>I</given-names></name><name><surname>Guarducci</surname> <given-names>E</given-names></name><name><surname>Balercia</surname> <given-names>G</given-names></name><name><surname>Forti</surname> <given-names>G</given-names></name><name><surname>Krausz</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Partial AZFc deletions and duplications: clinical correlates in the italian population</article-title><source>Human Genetics</source><volume>124</volume><fpage>399</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1007/s00439-008-0561-1</pub-id><pub-id pub-id-type="pmid">18807255</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grigorova</surname> <given-names>M</given-names></name><name><surname>Punab</surname> <given-names>M</given-names></name><name><surname>Ausmees</surname> <given-names>K</given-names></name><name><surname>Laan</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men</article-title><source>Human Reproduction</source><volume>23</volume><fpage>2160</fpage><lpage>2166</lpage><pub-id pub-id-type="doi">10.1093/humrep/den216</pub-id><pub-id pub-id-type="pmid">18567894</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallast</surname> <given-names>P</given-names></name><name><surname>Balaresque</surname> <given-names>P</given-names></name><name><surname>Bowden</surname> <given-names>GR</given-names></name><name><surname>Ballereau</surname> <given-names>S</given-names></name><name><surname>Jobling</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Recombination dynamics of a human Y-chromosomal palindrome: rapid GC-biased gene conversion, multi-kilobase conversion tracts, and rare inversions</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003666</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003666</pub-id><pub-id pub-id-type="pmid">23935520</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilumäe</surname> <given-names>AM</given-names></name><name><surname>Reidla</surname> <given-names>M</given-names></name><name><surname>Chukhryaeva</surname> <given-names>M</given-names></name><name><surname>Järve</surname> <given-names>M</given-names></name><name><surname>Post</surname> <given-names>H</given-names></name><name><surname>Karmin</surname> <given-names>M</given-names></name><name><surname>Saag</surname> <given-names>L</given-names></name><name><surname>Agdzhoyan</surname> <given-names>A</given-names></name><name><surname>Kushniarevich</surname> <given-names>A</given-names></name><name><surname>Litvinov</surname> <given-names>S</given-names></name><name><surname>Ekomasova</surname> <given-names>N</given-names></name><name><surname>Tambets</surname> <given-names>K</given-names></name><name><surname>Metspalu</surname> <given-names>E</given-names></name><name><surname>Khusainova</surname> <given-names>R</given-names></name><name><surname>Yunusbayev</surname> <given-names>B</given-names></name><name><surname>Khusnutdinova</surname> <given-names>EK</given-names></name><name><surname>Osipova</surname> <given-names>LP</given-names></name><name><surname>Fedorova</surname> <given-names>S</given-names></name><name><surname>Utevska</surname> <given-names>O</given-names></name><name><surname>Koshel</surname> <given-names>S</given-names></name><name><surname>Balanovska</surname> <given-names>E</given-names></name><name><surname>Behar</surname> <given-names>DM</given-names></name><name><surname>Balanovsky</surname> <given-names>O</given-names></name><name><surname>Kivisild</surname> <given-names>T</given-names></name><name><surname>Underhill</surname> <given-names>PA</given-names></name><name><surname>Villems</surname> <given-names>R</given-names></name><name><surname>Rootsi</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Human Y chromosome haplogroup N: a Non-trivial Time-Resolved phylogeography that cuts across language families</article-title><source>The American Journal of Human Genetics</source><volume>99</volume><fpage>163</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2016.05.025</pub-id><pub-id pub-id-type="pmid">27392075</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jobling</surname> <given-names>MA</given-names></name><name><surname>Tyler-Smith</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Human Y-chromosome variation in the genome-sequencing era</article-title><source>Nature Reviews Genetics</source><volume>18</volume><fpage>485</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1038/nrg.2017.36</pub-id><pub-id pub-id-type="pmid">28555659</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname> <given-names>MM</given-names></name><name><surname>Pottmeier</surname> <given-names>P</given-names></name><name><surname>Suciu</surname> <given-names>P</given-names></name><name><surname>Ahmad</surname> <given-names>T</given-names></name><name><surname>Zaghlool</surname> <given-names>A</given-names></name><name><surname>Halvardson</surname> <given-names>J</given-names></name><name><surname>Darj</surname> <given-names>E</given-names></name><name><surname>Feuk</surname> <given-names>L</given-names></name><name><surname>Peuckert</surname> <given-names>C</given-names></name><name><surname>Jazin</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Novel Y-Chromosome long Non-Coding RNAs expressed in human male CNS during early development</article-title><source>Frontiers in Genetics</source><volume>10</volume><elocation-id>891</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2019.00891</pub-id><pub-id pub-id-type="pmid">31608120</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jungwirth</surname> <given-names>A</given-names></name><name><surname>Giwercman</surname> <given-names>A</given-names></name><name><surname>Tournaye</surname> <given-names>H</given-names></name><name><surname>Diemer</surname> <given-names>T</given-names></name><name><surname>Kopa</surname> <given-names>Z</given-names></name><name><surname>Dohle</surname> <given-names>G</given-names></name><name><surname>Krausz</surname> <given-names>CI</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>European association of urology working group on male, european association of urology guidelines on male infertility: the 2012 update</article-title><source>European Urology</source><volume>62</volume><fpage>324</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2012.04.048</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karmin</surname> <given-names>M</given-names></name><name><surname>Saag</surname> <given-names>L</given-names></name><name><surname>Vicente</surname> <given-names>M</given-names></name><name><surname>Wilson Sayres</surname> <given-names>MA</given-names></name><name><surname>Järve</surname> <given-names>M</given-names></name><name><surname>Talas</surname> <given-names>UG</given-names></name><name><surname>Rootsi</surname> <given-names>S</given-names></name><name><surname>Ilumäe</surname> <given-names>AM</given-names></name><name><surname>Mägi</surname> <given-names>R</given-names></name><name><surname>Mitt</surname> <given-names>M</given-names></name><name><surname>Pagani</surname> <given-names>L</given-names></name><name><surname>Puurand</surname> <given-names>T</given-names></name><name><surname>Faltyskova</surname> <given-names>Z</given-names></name><name><surname>Clemente</surname> <given-names>F</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name><name><surname>Metspalu</surname> <given-names>E</given-names></name><name><surname>Sahakyan</surname> <given-names>H</given-names></name><name><surname>Yunusbayev</surname> <given-names>B</given-names></name><name><surname>Hudjashov</surname> <given-names>G</given-names></name><name><surname>DeGiorgio</surname> <given-names>M</given-names></name><name><surname>Loogväli</surname> <given-names>EL</given-names></name><name><surname>Eichstaedt</surname> <given-names>C</given-names></name><name><surname>Eelmets</surname> <given-names>M</given-names></name><name><surname>Chaubey</surname> <given-names>G</given-names></name><name><surname>Tambets</surname> <given-names>K</given-names></name><name><surname>Litvinov</surname> <given-names>S</given-names></name><name><surname>Mormina</surname> <given-names>M</given-names></name><name><surname>Xue</surname> <given-names>Y</given-names></name><name><surname>Ayub</surname> <given-names>Q</given-names></name><name><surname>Zoraqi</surname> <given-names>G</given-names></name><name><surname>Korneliussen</surname> <given-names>TS</given-names></name><name><surname>Akhatova</surname> <given-names>F</given-names></name><name><surname>Lachance</surname> <given-names>J</given-names></name><name><surname>Tishkoff</surname> <given-names>S</given-names></name><name><surname>Momynaliev</surname> <given-names>K</given-names></name><name><surname>Ricaut</surname> <given-names>FX</given-names></name><name><surname>Kusuma</surname> <given-names>P</given-names></name><name><surname>Razafindrazaka</surname> <given-names>H</given-names></name><name><surname>Pierron</surname> <given-names>D</given-names></name><name><surname>Cox</surname> <given-names>MP</given-names></name><name><surname>Sultana</surname> <given-names>GN</given-names></name><name><surname>Willerslev</surname> <given-names>R</given-names></name><name><surname>Muller</surname> <given-names>C</given-names></name><name><surname>Westaway</surname> <given-names>M</given-names></name><name><surname>Lambert</surname> <given-names>D</given-names></name><name><surname>Skaro</surname> <given-names>V</given-names></name><name><surname>Kovačevic</surname> <given-names>L</given-names></name><name><surname>Turdikulova</surname> <given-names>S</given-names></name><name><surname>Dalimova</surname> <given-names>D</given-names></name><name><surname>Khusainova</surname> <given-names>R</given-names></name><name><surname>Trofimova</surname> <given-names>N</given-names></name><name><surname>Akhmetova</surname> <given-names>V</given-names></name><name><surname>Khidiyatova</surname> <given-names>I</given-names></name><name><surname>Lichman</surname> <given-names>DV</given-names></name><name><surname>Isakova</surname> <given-names>J</given-names></name><name><surname>Pocheshkhova</surname> <given-names>E</given-names></name><name><surname>Sabitov</surname> <given-names>Z</given-names></name><name><surname>Barashkov</surname> <given-names>NA</given-names></name><name><surname>Nymadawa</surname> <given-names>P</given-names></name><name><surname>Mihailov</surname> <given-names>E</given-names></name><name><surname>Seng</surname> <given-names>JW</given-names></name><name><surname>Evseeva</surname> <given-names>I</given-names></name><name><surname>Migliano</surname> <given-names>AB</given-names></name><name><surname>Abdullah</surname> <given-names>S</given-names></name><name><surname>Andriadze</surname> <given-names>G</given-names></name><name><surname>Primorac</surname> <given-names>D</given-names></name><name><surname>Atramentova</surname> <given-names>L</given-names></name><name><surname>Utevska</surname> <given-names>O</given-names></name><name><surname>Yepiskoposyan</surname> <given-names>L</given-names></name><name><surname>Marjanovic</surname> <given-names>D</given-names></name><name><surname>Kushniarevich</surname> <given-names>A</given-names></name><name><surname>Behar</surname> <given-names>DM</given-names></name><name><surname>Gilissen</surname> <given-names>C</given-names></name><name><surname>Vissers</surname> <given-names>L</given-names></name><name><surname>Veltman</surname> <given-names>JA</given-names></name><name><surname>Balanovska</surname> <given-names>E</given-names></name><name><surname>Derenko</surname> <given-names>M</given-names></name><name><surname>Malyarchuk</surname> <given-names>B</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>Fedorova</surname> <given-names>S</given-names></name><name><surname>Eriksson</surname> <given-names>A</given-names></name><name><surname>Manica</surname> <given-names>A</given-names></name><name><surname>Mendez</surname> <given-names>FL</given-names></name><name><surname>Karafet</surname> <given-names>TM</given-names></name><name><surname>Veeramah</surname> <given-names>KR</given-names></name><name><surname>Bradman</surname> <given-names>N</given-names></name><name><surname>Hammer</surname> <given-names>MF</given-names></name><name><surname>Osipova</surname> <given-names>LP</given-names></name><name><surname>Balanovsky</surname> <given-names>O</given-names></name><name><surname>Khusnutdinova</surname> <given-names>EK</given-names></name><name><surname>Johnsen</surname> <given-names>K</given-names></name><name><surname>Remm</surname> <given-names>M</given-names></name><name><surname>Thomas</surname> <given-names>MG</given-names></name><name><surname>Tyler-Smith</surname> <given-names>C</given-names></name><name><surname>Underhill</surname> <given-names>PA</given-names></name><name><surname>Willerslev</surname> <given-names>E</given-names></name><name><surname>Nielsen</surname> <given-names>R</given-names></name><name><surname>Metspalu</surname> <given-names>M</given-names></name><name><surname>Villems</surname> <given-names>R</given-names></name><name><surname>Kivisild</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A recent bottleneck of Y chromosome diversity coincides with a global change in culture</article-title><source>Genome Research</source><volume>25</volume><fpage>459</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1101/gr.186684.114</pub-id><pub-id pub-id-type="pmid">25770088</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikas</surname> <given-names>T</given-names></name><name><surname>Inno</surname> <given-names>R</given-names></name><name><surname>Ratnik</surname> <given-names>K</given-names></name><name><surname>Rull</surname> <given-names>K</given-names></name><name><surname>Laan</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>C-allele of rs4769613 near <italic>FLT1</italic> represents a High-Confidence placental risk factor for preeclampsia</article-title><source>Hypertension</source><volume>76</volume><fpage>884</fpage><lpage>891</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.120.15346</pub-id><pub-id pub-id-type="pmid">32755415</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohn</surname> <given-names>TP</given-names></name><name><surname>Kohn</surname> <given-names>JR</given-names></name><name><surname>Owen</surname> <given-names>RC</given-names></name><name><surname>Coward</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The prevalence of Y-chromosome microdeletions in Oligozoospermic men: a systematic review and Meta-analysis of european and north american studies</article-title><source>European Urology</source><volume>76</volume><fpage>626</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2019.07.033</pub-id><pub-id pub-id-type="pmid">31400948</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krausz</surname> <given-names>C</given-names></name><name><surname>Giachini</surname> <given-names>C</given-names></name><name><surname>Xue</surname> <given-names>Y</given-names></name><name><surname>O'Bryan</surname> <given-names>MK</given-names></name><name><surname>Gromoll</surname> <given-names>J</given-names></name><name><surname>Rajpert-de Meyts</surname> <given-names>E</given-names></name><name><surname>Oliva</surname> <given-names>R</given-names></name><name><surname>Aknin-Seifer</surname> <given-names>I</given-names></name><name><surname>Erdei</surname> <given-names>E</given-names></name><name><surname>Jorgensen</surname> <given-names>N</given-names></name><name><surname>Simoni</surname> <given-names>M</given-names></name><name><surname>Ballescà</surname> <given-names>JL</given-names></name><name><surname>Levy</surname> <given-names>R</given-names></name><name><surname>Balercia</surname> <given-names>G</given-names></name><name><surname>Piomboni</surname> <given-names>P</given-names></name><name><surname>Nieschlag</surname> <given-names>E</given-names></name><name><surname>Forti</surname> <given-names>G</given-names></name><name><surname>McLachlan</surname> <given-names>R</given-names></name><name><surname>Tyler-Smith</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Phenotypic variation within european carriers of the Y-chromosomal gr/gr deletion is independent of Y-chromosomal background</article-title><source>Journal of Medical Genetics</source><volume>46</volume><fpage>21</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1136/jmg.2008.059915</pub-id><pub-id pub-id-type="pmid">18782837</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krausz</surname> <given-names>C</given-names></name><name><surname>Hoefsloot</surname> <given-names>L</given-names></name><name><surname>Simoni</surname> <given-names>M</given-names></name><name><surname>Tüttelmann</surname> <given-names>F</given-names></name><collab>European Academy of Andrology</collab><collab>European Molecular Genetics Quality Network</collab></person-group><year iso-8601-date="2014">2014</year><article-title>EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: state-of-the-art 2013</article-title><source>Andrology</source><volume>2</volume><fpage>5</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1111/j.2047-2927.2013.00173.x</pub-id><pub-id pub-id-type="pmid">24357628</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krausz</surname> <given-names>C</given-names></name><name><surname>Casamonti</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Spermatogenic failure and the Y chromosome</article-title><source>Human Genetics</source><volume>136</volume><fpage>637</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1007/s00439-017-1793-8</pub-id><pub-id pub-id-type="pmid">28456834</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroda-Kawaguchi</surname> <given-names>T</given-names></name><name><surname>Skaletsky</surname> <given-names>H</given-names></name><name><surname>Brown</surname> <given-names>LG</given-names></name><name><surname>Minx</surname> <given-names>PJ</given-names></name><name><surname>Cordum</surname> <given-names>HS</given-names></name><name><surname>Waterston</surname> <given-names>RH</given-names></name><name><surname>Wilson</surname> <given-names>RK</given-names></name><name><surname>Silber</surname> <given-names>S</given-names></name><name><surname>Oates</surname> <given-names>R</given-names></name><name><surname>Rozen</surname> <given-names>S</given-names></name><name><surname>Page</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men</article-title><source>Nature Genetics</source><volume>29</volume><fpage>279</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1038/ng757</pub-id><pub-id pub-id-type="pmid">11687796</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Durbin</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title><source>Bioinformatics</source><volume>25</volume><fpage>1754</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id><pub-id pub-id-type="pmid">19451168</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>YW</given-names></name><name><surname>Hsu</surname> <given-names>CL</given-names></name><name><surname>Yen</surname> <given-names>PH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A two-step protocol for the detection of rearrangements at the AZFc region on the human Y chromosome</article-title><source>Molecular Human Reproduction</source><volume>12</volume><fpage>347</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1093/molehr/gal038</pub-id><pub-id pub-id-type="pmid">16608905</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>YW</given-names></name><name><surname>Hsu</surname> <given-names>LC</given-names></name><name><surname>Kuo</surname> <given-names>PL</given-names></name><name><surname>Huang</surname> <given-names>WJ</given-names></name><name><surname>Chiang</surname> <given-names>HS</given-names></name><name><surname>Yeh</surname> <given-names>SD</given-names></name><name><surname>Hsu</surname> <given-names>TY</given-names></name><name><surname>Yu</surname> <given-names>YH</given-names></name><name><surname>Hsiao</surname> <given-names>KN</given-names></name><name><surname>Cantor</surname> <given-names>RM</given-names></name><name><surname>Yen</surname> <given-names>PH</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Partial duplication at <italic>AZFc</italic> on the Y chromosome is a risk factor for impaired spermatogenesis in han chinese in Taiwan</article-title><source>Human Mutation</source><volume>28</volume><fpage>486</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1002/humu.20473</pub-id><pub-id pub-id-type="pmid">17285591</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Giacco</surname> <given-names>D</given-names></name><name><surname>Chianese</surname> <given-names>C</given-names></name><name><surname>Sánchez-Curbelo</surname> <given-names>J</given-names></name><name><surname>Bassas</surname> <given-names>L</given-names></name><name><surname>Ruiz</surname> <given-names>P</given-names></name><name><surname>Rajmil</surname> <given-names>O</given-names></name><name><surname>Sarquella</surname> <given-names>J</given-names></name><name><surname>Vives</surname> <given-names>A</given-names></name><name><surname>Ruiz-Castañé</surname> <given-names>E</given-names></name><name><surname>Oliva</surname> <given-names>R</given-names></name><name><surname>Ars</surname> <given-names>E</given-names></name><name><surname>Krausz</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Clinical relevance of Y-linked CNV screening in male infertility: new insights based on the 8-year experience of a diagnostic genetic laboratory</article-title><source>European Journal of Human Genetics</source><volume>22</volume><fpage>754</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2013.253</pub-id><pub-id pub-id-type="pmid">24193344</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>C</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Yang</surname> <given-names>H</given-names></name><name><surname>Xu</surname> <given-names>M</given-names></name><name><surname>Du</surname> <given-names>G</given-names></name><name><surname>Wu</surname> <given-names>W</given-names></name><name><surname>An</surname> <given-names>Y</given-names></name><name><surname>Qin</surname> <given-names>Y</given-names></name><name><surname>Ji</surname> <given-names>G</given-names></name><name><surname>Han</surname> <given-names>X</given-names></name><name><surname>Gu</surname> <given-names>A</given-names></name><name><surname>Xia</surname> <given-names>Y</given-names></name><name><surname>Song</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Jin</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Additional genomic duplications in AZFc underlie the b2/b3 deletion-associated risk of spermatogenic impairment in han chinese population</article-title><source>Human Molecular Genetics</source><volume>20</volume><fpage>4411</fpage><lpage>4421</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddr369</pub-id><pub-id pub-id-type="pmid">21852246</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machev</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Sequence family variant loss from the AZFc interval of the human Y chromosome, but not gene copy loss, is strongly associated with male infertility</article-title><source>Journal of Medical Genetics</source><volume>41</volume><fpage>814</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1136/jmg.2004.022111</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenna</surname> <given-names>A</given-names></name><name><surname>Hanna</surname> <given-names>M</given-names></name><name><surname>Banks</surname> <given-names>E</given-names></name><name><surname>Sivachenko</surname> <given-names>A</given-names></name><name><surname>Cibulskis</surname> <given-names>K</given-names></name><name><surname>Kernytsky</surname> <given-names>A</given-names></name><name><surname>Garimella</surname> <given-names>K</given-names></name><name><surname>Altshuler</surname> <given-names>D</given-names></name><name><surname>Gabriel</surname> <given-names>S</given-names></name><name><surname>Daly</surname> <given-names>M</given-names></name><name><surname>DePristo</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</article-title><source>Genome Research</source><volume>20</volume><fpage>1297</fpage><lpage>1303</lpage><pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id><pub-id pub-id-type="pmid">20644199</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLaren</surname> <given-names>W</given-names></name><name><surname>Gil</surname> <given-names>L</given-names></name><name><surname>Hunt</surname> <given-names>SE</given-names></name><name><surname>Riat</surname> <given-names>HS</given-names></name><name><surname>Ritchie</surname> <given-names>GR</given-names></name><name><surname>Thormann</surname> <given-names>A</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name><name><surname>Cunningham</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The ensembl variant effect predictor</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>122</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-0974-4</pub-id><pub-id pub-id-type="pmid">27268795</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noordam</surname> <given-names>MJ</given-names></name><name><surname>Westerveld</surname> <given-names>GH</given-names></name><name><surname>Hovingh</surname> <given-names>SE</given-names></name><name><surname>van Daalen</surname> <given-names>SK</given-names></name><name><surname>Korver</surname> <given-names>CM</given-names></name><name><surname>van der Veen</surname> <given-names>F</given-names></name><name><surname>van Pelt</surname> <given-names>AM</given-names></name><name><surname>Repping</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Gene copy number reduction in the azoospermia factor c (AZFc) region and its effect on total motile sperm count</article-title><source>Human Molecular Genetics</source><volume>20</volume><fpage>2457</fpage><lpage>2463</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddr119</pub-id><pub-id pub-id-type="pmid">21429917</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olesen</surname> <given-names>IA</given-names></name><name><surname>Andersson</surname> <given-names>AM</given-names></name><name><surname>Aksglaede</surname> <given-names>L</given-names></name><name><surname>Skakkebaek</surname> <given-names>NE</given-names></name><name><surname>Rajpert-de Meyts</surname> <given-names>E</given-names></name><name><surname>Joergensen</surname> <given-names>N</given-names></name><name><surname>Juul</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Clinical, genetic, biochemical, and testicular biopsy findings among 1,213 men evaluated for infertility</article-title><source>Fertility and Sterility</source><volume>107</volume><fpage>74</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.fertnstert.2016.09.015</pub-id><pub-id pub-id-type="pmid">27793385</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilvar</surname> <given-names>D</given-names></name><name><surname>Reiman</surname> <given-names>M</given-names></name><name><surname>Pilvar</surname> <given-names>A</given-names></name><name><surname>Laan</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Parent-of-origin-specific allelic expression in the human placenta is limited to established imprinted loci and it is stably maintained across pregnancy</article-title><source>Clinical Epigenetics</source><volume>11</volume><elocation-id>94</elocation-id><pub-id pub-id-type="doi">10.1186/s13148-019-0692-3</pub-id><pub-id pub-id-type="pmid">31242935</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Punab</surname> <given-names>M</given-names></name><name><surname>Poolamets</surname> <given-names>O</given-names></name><name><surname>Paju</surname> <given-names>P</given-names></name><name><surname>Vihljajev</surname> <given-names>V</given-names></name><name><surname>Pomm</surname> <given-names>K</given-names></name><name><surname>Ladva</surname> <given-names>R</given-names></name><name><surname>Korrovits</surname> <given-names>P</given-names></name><name><surname>Laan</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Causes of male infertility: a 9-year prospective monocentre study on 1737 patients with reduced total sperm counts</article-title><source>Human Reproduction</source><volume>32</volume><fpage>18</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1093/humrep/dew284</pub-id><pub-id pub-id-type="pmid">27864361</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rentzsch</surname> <given-names>P</given-names></name><name><surname>Witten</surname> <given-names>D</given-names></name><name><surname>Cooper</surname> <given-names>GM</given-names></name><name><surname>Shendure</surname> <given-names>J</given-names></name><name><surname>Kircher</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CADD: predicting the deleteriousness of variants throughout the human genome</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D886</fpage><lpage>D894</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1016</pub-id><pub-id pub-id-type="pmid">30371827</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Repping</surname> <given-names>S</given-names></name><name><surname>Skaletsky</surname> <given-names>H</given-names></name><name><surname>Brown</surname> <given-names>L</given-names></name><name><surname>van Daalen</surname> <given-names>SK</given-names></name><name><surname>Korver</surname> <given-names>CM</given-names></name><name><surname>Pyntikova</surname> <given-names>T</given-names></name><name><surname>Kuroda-Kawaguchi</surname> <given-names>T</given-names></name><name><surname>de Vries</surname> <given-names>JW</given-names></name><name><surname>Oates</surname> <given-names>RD</given-names></name><name><surname>Silber</surname> <given-names>S</given-names></name><name><surname>van der Veen</surname> <given-names>F</given-names></name><name><surname>Page</surname> <given-names>DC</given-names></name><name><surname>Rozen</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Polymorphism for a 1.6-Mb deletion of the human Y chromosome persists through balance between recurrent mutation and haploid selection</article-title><source>Nature Genetics</source><volume>35</volume><fpage>247</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1038/ng1250</pub-id><pub-id pub-id-type="pmid">14528305</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Repping</surname> <given-names>S</given-names></name><name><surname>van Daalen</surname> <given-names>SK</given-names></name><name><surname>Korver</surname> <given-names>CM</given-names></name><name><surname>Brown</surname> <given-names>LG</given-names></name><name><surname>Marszalek</surname> <given-names>JD</given-names></name><name><surname>Gianotten</surname> <given-names>J</given-names></name><name><surname>Oates</surname> <given-names>RD</given-names></name><name><surname>Silber</surname> <given-names>S</given-names></name><name><surname>van der Veen</surname> <given-names>F</given-names></name><name><surname>Page</surname> <given-names>DC</given-names></name><name><surname>Rozen</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A family of human Y chromosomes has dispersed throughout northern eurasia despite a 1.8-Mb deletion in the azoospermia factor c region</article-title><source>Genomics</source><volume>83</volume><fpage>1046</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.1016/j.ygeno.2003.12.018</pub-id><pub-id pub-id-type="pmid">15177557</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozen</surname> <given-names>S</given-names></name><name><surname>Skaletsky</surname> <given-names>H</given-names></name><name><surname>Marszalek</surname> <given-names>JD</given-names></name><name><surname>Minx</surname> <given-names>PJ</given-names></name><name><surname>Cordum</surname> <given-names>HS</given-names></name><name><surname>Waterston</surname> <given-names>RH</given-names></name><name><surname>Wilson</surname> <given-names>RK</given-names></name><name><surname>Page</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Abundant gene conversion between arms of palindromes in human and ape Y chromosomes</article-title><source>Nature</source><volume>423</volume><fpage>873</fpage><lpage>876</lpage><pub-id pub-id-type="doi">10.1038/nature01723</pub-id><pub-id pub-id-type="pmid">12815433</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozen</surname> <given-names>SG</given-names></name><name><surname>Marszalek</surname> <given-names>JD</given-names></name><name><surname>Irenze</surname> <given-names>K</given-names></name><name><surname>Skaletsky</surname> <given-names>H</given-names></name><name><surname>Brown</surname> <given-names>LG</given-names></name><name><surname>Oates</surname> <given-names>RD</given-names></name><name><surname>Silber</surname> <given-names>SJ</given-names></name><name><surname>Ardlie</surname> <given-names>K</given-names></name><name><surname>Page</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>AZFc deletions and spermatogenic failure: a population-based survey of 20,000 Y chromosomes</article-title><source>The American Journal of Human Genetics</source><volume>91</volume><fpage>890</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2012.09.003</pub-id><pub-id pub-id-type="pmid">23103232</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>W</given-names></name><name><surname>Louzada</surname> <given-names>S</given-names></name><name><surname>Grigorova</surname> <given-names>M</given-names></name><name><surname>Massaia</surname> <given-names>A</given-names></name><name><surname>Arciero</surname> <given-names>E</given-names></name><name><surname>Kibena</surname> <given-names>L</given-names></name><name><surname>Ge</surname> <given-names>XJ</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Ayub</surname> <given-names>Q</given-names></name><name><surname>Poolamets</surname> <given-names>O</given-names></name><name><surname>Tyler-Smith</surname> <given-names>C</given-names></name><name><surname>Punab</surname> <given-names>M</given-names></name><name><surname>Laan</surname> <given-names>M</given-names></name><name><surname>Yang</surname> <given-names>F</given-names></name><name><surname>Hallast</surname> <given-names>P</given-names></name><name><surname>Xue</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Evolutionary and functional analysis of RBMY1 gene copy number variation on the human Y chromosome</article-title><source>Human Molecular Genetics</source><volume>28</volume><fpage>2785</fpage><lpage>2798</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddz101</pub-id><pub-id pub-id-type="pmid">31108506</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skaletsky</surname> <given-names>H</given-names></name><name><surname>Kuroda-Kawaguchi</surname> <given-names>T</given-names></name><name><surname>Minx</surname> <given-names>PJ</given-names></name><name><surname>Cordum</surname> <given-names>HS</given-names></name><name><surname>Hillier</surname> <given-names>L</given-names></name><name><surname>Brown</surname> <given-names>LG</given-names></name><name><surname>Repping</surname> <given-names>S</given-names></name><name><surname>Pyntikova</surname> <given-names>T</given-names></name><name><surname>Ali</surname> <given-names>J</given-names></name><name><surname>Bieri</surname> <given-names>T</given-names></name><name><surname>Chinwalla</surname> <given-names>A</given-names></name><name><surname>Delehaunty</surname> <given-names>A</given-names></name><name><surname>Delehaunty</surname> <given-names>K</given-names></name><name><surname>Du</surname> <given-names>H</given-names></name><name><surname>Fewell</surname> <given-names>G</given-names></name><name><surname>Fulton</surname> <given-names>L</given-names></name><name><surname>Fulton</surname> <given-names>R</given-names></name><name><surname>Graves</surname> <given-names>T</given-names></name><name><surname>Hou</surname> <given-names>SF</given-names></name><name><surname>Latrielle</surname> <given-names>P</given-names></name><name><surname>Leonard</surname> <given-names>S</given-names></name><name><surname>Mardis</surname> <given-names>E</given-names></name><name><surname>Maupin</surname> <given-names>R</given-names></name><name><surname>McPherson</surname> <given-names>J</given-names></name><name><surname>Miner</surname> <given-names>T</given-names></name><name><surname>Nash</surname> <given-names>W</given-names></name><name><surname>Nguyen</surname> <given-names>C</given-names></name><name><surname>Ozersky</surname> <given-names>P</given-names></name><name><surname>Pepin</surname> <given-names>K</given-names></name><name><surname>Rock</surname> <given-names>S</given-names></name><name><surname>Rohlfing</surname> <given-names>T</given-names></name><name><surname>Scott</surname> <given-names>K</given-names></name><name><surname>Schultz</surname> <given-names>B</given-names></name><name><surname>Strong</surname> <given-names>C</given-names></name><name><surname>Tin-Wollam</surname> <given-names>A</given-names></name><name><surname>Yang</surname> <given-names>SP</given-names></name><name><surname>Waterston</surname> <given-names>RH</given-names></name><name><surname>Wilson</surname> <given-names>RK</given-names></name><name><surname>Rozen</surname> <given-names>S</given-names></name><name><surname>Page</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes</article-title><source>Nature</source><volume>423</volume><fpage>825</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1038/nature01722</pub-id><pub-id pub-id-type="pmid">12815422</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stahl</surname> <given-names>PJ</given-names></name><name><surname>Masson</surname> <given-names>P</given-names></name><name><surname>Mielnik</surname> <given-names>A</given-names></name><name><surname>Marean</surname> <given-names>MB</given-names></name><name><surname>Schlegel</surname> <given-names>PN</given-names></name><name><surname>Paduch</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A decade of experience emphasizes that testing for Y microdeletions is essential in american men with azoospermia and severe oligozoospermia</article-title><source>Fertility and Sterility</source><volume>94</volume><fpage>1753</fpage><lpage>1756</lpage><pub-id pub-id-type="doi">10.1016/j.fertnstert.2009.09.006</pub-id><pub-id pub-id-type="pmid">19896650</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teitz</surname> <given-names>LS</given-names></name><name><surname>Pyntikova</surname> <given-names>T</given-names></name><name><surname>Skaletsky</surname> <given-names>H</given-names></name><name><surname>Page</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Selection has countered high mutability to preserve the ancestral copy number of Y chromosome amplicons in diverse human lineages</article-title><source>The American Journal of Human Genetics</source><volume>103</volume><fpage>261</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2018.07.007</pub-id><pub-id pub-id-type="pmid">30075113</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trombetta</surname> <given-names>B</given-names></name><name><surname>Cruciani</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Y chromosome palindromes and gene conversion</article-title><source>Human Genetics</source><volume>136</volume><fpage>605</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1007/s00439-017-1777-8</pub-id><pub-id pub-id-type="pmid">28303348</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tüttelmann</surname> <given-names>F</given-names></name><name><surname>Werny</surname> <given-names>F</given-names></name><name><surname>Cooper</surname> <given-names>TG</given-names></name><name><surname>Kliesch</surname> <given-names>S</given-names></name><name><surname>Simoni</surname> <given-names>M</given-names></name><name><surname>Nieschlag</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Clinical experience with azoospermia: aetiology and chances for spermatozoa detection upon biopsy</article-title><source>International Journal of Andrology</source><volume>34</volume><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2605.2010.01087.x</pub-id><pub-id pub-id-type="pmid">20609027</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Underhill</surname> <given-names>PA</given-names></name><name><surname>Poznik</surname> <given-names>GD</given-names></name><name><surname>Rootsi</surname> <given-names>S</given-names></name><name><surname>Järve</surname> <given-names>M</given-names></name><name><surname>Lin</surname> <given-names>AA</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Passarelli</surname> <given-names>B</given-names></name><name><surname>Kanbar</surname> <given-names>J</given-names></name><name><surname>Myres</surname> <given-names>NM</given-names></name><name><surname>King</surname> <given-names>RJ</given-names></name><name><surname>Di Cristofaro</surname> <given-names>J</given-names></name><name><surname>Sahakyan</surname> <given-names>H</given-names></name><name><surname>Behar</surname> <given-names>DM</given-names></name><name><surname>Kushniarevich</surname> <given-names>A</given-names></name><name><surname>Sarac</surname> <given-names>J</given-names></name><name><surname>Saric</surname> <given-names>T</given-names></name><name><surname>Rudan</surname> <given-names>P</given-names></name><name><surname>Pathak</surname> <given-names>AK</given-names></name><name><surname>Chaubey</surname> <given-names>G</given-names></name><name><surname>Grugni</surname> <given-names>V</given-names></name><name><surname>Semino</surname> <given-names>O</given-names></name><name><surname>Yepiskoposyan</surname> <given-names>L</given-names></name><name><surname>Bahmanimehr</surname> <given-names>A</given-names></name><name><surname>Farjadian</surname> <given-names>S</given-names></name><name><surname>Balanovsky</surname> <given-names>O</given-names></name><name><surname>Khusnutdinova</surname> <given-names>EK</given-names></name><name><surname>Herrera</surname> <given-names>RJ</given-names></name><name><surname>Chiaroni</surname> <given-names>J</given-names></name><name><surname>Bustamante</surname> <given-names>CD</given-names></name><name><surname>Quake</surname> <given-names>SR</given-names></name><name><surname>Kivisild</surname> <given-names>T</given-names></name><name><surname>Villems</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The phylogenetic and geographic structure of Y-chromosome haplogroup R1a</article-title><source>European Journal of Human Genetics</source><volume>23</volume><fpage>124</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2014.50</pub-id><pub-id pub-id-type="pmid">24667786</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><source>Ggplot2: Elegant Graphics for Data Analysis</source><publisher-loc>New York</publisher-loc><publisher-name>Springer-Verlag</publisher-name><pub-id pub-id-type="doi">10.1007/978-0-387-98141-3</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><year iso-8601-date="2010">2010</year><source>WHO Laboratory Manual for the Examination and Processing of Human Semen</source><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Ma</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Su</surname> <given-names>D</given-names></name><name><surname>Chen</surname> <given-names>P</given-names></name><name><surname>Ma</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Tao</surname> <given-names>D</given-names></name><name><surname>Lin</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Differential effect of specific gr/gr deletion subtypes on spermatogenesis in the chinese han population</article-title><source>International Journal of Andrology</source><volume>33</volume><fpage>745</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2605.2009.01015.x</pub-id><pub-id pub-id-type="pmid">20039973</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>B</given-names></name><name><surname>Ma</surname> <given-names>YY</given-names></name><name><surname>Liu</surname> <given-names>YQ</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Yang</surname> <given-names>D</given-names></name><name><surname>Tu</surname> <given-names>WL</given-names></name><name><surname>Shen</surname> <given-names>Y</given-names></name><name><surname>Dong</surname> <given-names>Q</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Common AZFc structure may possess the optimal spermatogenesis efficiency relative to the rearranged structures mediated by non-allele homologous recombination</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>10551</elocation-id><pub-id pub-id-type="doi">10.1038/srep10551</pub-id><pub-id pub-id-type="pmid">26000765</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>JJ</given-names></name><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Yang</surname> <given-names>LJ</given-names></name><name><surname>Wang</surname> <given-names>JH</given-names></name><name><surname>Wang</surname> <given-names>YL</given-names></name><name><surname>Guo</surname> <given-names>H</given-names></name><name><surname>Gong</surname> <given-names>N</given-names></name><name><surname>Nie</surname> <given-names>WH</given-names></name><name><surname>Zhao</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Partial AZFc duplications not deletions are associated with male infertility in the yi population of Yunnan Province, China</article-title><source>Journal of Zhejiang University. Science. B</source><volume>14</volume><fpage>807</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1631/jzus.B1200301</pub-id><pub-id pub-id-type="pmid">24009201</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zerjal</surname> <given-names>T</given-names></name><name><surname>Dashnyam</surname> <given-names>B</given-names></name><name><surname>Pandya</surname> <given-names>A</given-names></name><name><surname>Kayser</surname> <given-names>M</given-names></name><name><surname>Roewer</surname> <given-names>L</given-names></name><name><surname>Santos</surname> <given-names>FR</given-names></name><name><surname>Schiefenhövel</surname> <given-names>W</given-names></name><name><surname>Fretwell</surname> <given-names>N</given-names></name><name><surname>Jobling</surname> <given-names>MA</given-names></name><name><surname>Harihara</surname> <given-names>S</given-names></name><name><surname>Shimizu</surname> <given-names>K</given-names></name><name><surname>Semjidmaa</surname> <given-names>D</given-names></name><name><surname>Sajantila</surname> <given-names>A</given-names></name><name><surname>Salo</surname> <given-names>P</given-names></name><name><surname>Crawford</surname> <given-names>MH</given-names></name><name><surname>Ginter</surname> <given-names>EK</given-names></name><name><surname>Evgrafov</surname> <given-names>OV</given-names></name><name><surname>Tyler-Smith</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Genetic relationships of asians and northern europeans, revealed by Y-chromosomal DNA analysis</article-title><source>American Journal of Human Genetics</source><volume>60</volume><fpage>1174</fpage><lpage>1183</lpage><pub-id pub-id-type="pmid">9150165</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65420.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Perry</surname><given-names>George H</given-names></name><role>Reviewing Editor</role><aff><institution>Pennsylvania State University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/10.1101/2020.12.08.20245928">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.12.08.20245928v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This study presents extensive genetic analysis of a relatively large cohort of men with idiopathic infertility, with considerable accompanying andrological phenotypic data. Through careful step-by-step investigations, an inversion variant is identified as a risk factor for subsequent deletion variants that can lead to substantially increased risk of impaired spermatogenesis, on an age-structured basis, relative to non-carriers. As part of the most comprehensive investigation of <italic>AZFc</italic> microdeletions and structural variation to date, the authors have identified a novel structural variant of the Y-chromosome that predisposes to spermatogenic failure and provided clear guidelines for genetic counselling. This work will be of particular interest to the reproductive genetics field, but also has wide ranging implications for colleagues interested in common disease genetics, meiosis, structural variation, dosage sensitivity, and sex chromosome evolution.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;A common 1.6 Mb Y-chromosomal inversion predisposes to subsequent deletions and severe spermatogenic failure in humans&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by George Perry as the Senior Editor and Reviewing Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential Revisions:</p><p>1) Please compare the estimated cohort allele frequencies for each SV against corresponding gnomAD SV allele frequency estimates (https://gnomad.broadinstitute.org/; https://doi.org/10.1038/s41586-020-2287-8). If the novel risk alleles are represented in gnomAD SV, then this would help alleviate uncertainty around the genotyping. Furthermore, an estimate of the <italic>r2/r3</italic> inversion variant in both European and non-European populations would add important context and potential impact of the inversion+deletion risk allele. If any alleles are not represented in gnomAD SV the authors should comment as to why.</p><p>2) In general the primary genotyping data are underrepresented in the figures and supplement. For example, a histogram depicting estimated copy number from the ddPCR experiments would be useful. Good separation of the signal distributions centered around biologically interpretable copy numbers would indicate that the assay is well calibrated with minimal genotyping errors.</p><p>3) Are histopathology data from testis biopsies (e.g., see https://doi.org/10.1056/NEJMoa1406192) for cases with the risk allele available? This material may already be banked as part of the infertility workup. If so reporting of these results would be welcomed to help support the model of meiotic failure over gene dosage changes. If not, please mention this as a follow-up opportunity in your Discussion.</p><p>4) Please also discuss the potential future benefit (unless these data can be readily generated now) of long-read sequencing (e.g., ONT, PacBio) data to help resolve the relative orientations of the amplicons in one of their inversion+deletion patients. (A traditional cytogenetics approach (i.e., FISH with multiple colored probes) would also work but would require additional biological material). In particular, the long-read sequencing based approach has the added benefit of nominating a putative inversion breakpoint that could be fine-mapped and validated. The authors infer that the <italic>r2/r3</italic> inversion is a single, fixed lineage-specific event, but breakpoint information in multiple individuals would much more rigorously rule out a recurrent rearrangement scenario.</p><p>5) Also with respect to the request for slightly expanded Discussion, please offer some comments on potential approaches for (and or challenges associated with) replicating this result in another population/sample.</p><p>6) In the Results, please provide more explicit links to the specific assays/methods used to generate them, to aid reader understanding. For example, providing a short phrase that ddPCR (with a half-sentence description of the method) was used to quantify the <italic>DAZ</italic>, <italic>BPY2</italic>, and <italic>CDY</italic> genes. This information is laid out in the Materials and methods but adding to the Results will make the paper more readable. In addition, while the complexity and existing nomenclature of the AZF region contribute to the density of information in the Results section, as you identify descriptive wording that could be trimmed/compressed for readability, please make such changes.</p><p>7) Are the Pairwise Wilcoxon Rank Sum Test P-values in Figure 3 and Supplementary file 3 corrected for multiple tests? It's stated that the linear regression for Supplementary file 4 accounts for multiple tests only. Some P-values values in Supplementary file 3 are in bold but unless I'm missing it, it's not stated why.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65420.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential Revisions:</p><p>1) Please compare the estimated cohort allele frequencies for each SV against corresponding gnomAD SV allele frequency estimates (https://gnomad.broadinstitute.org/; https://doi.org/10.1038/s41586-020-2287-8). If the novel risk alleles are represented in gnomAD SV, then this would help alleviate uncertainty around the genotyping.</p></disp-quote><p>In gnomAD (v2.1) database, 15,708 whole-genome sequences have been targeted for SV calling. For the Y-chromosome, the number is 3-fold lower as the number of sequenced men is only ~5500. The Y-chromosomal haplogroup composition of these men is not known, but given the very broad demographic spread (~1700 Europeans, ~700 East Asians, ~2600 Africans etc), this is expected to be extremely diverse. Of note, the prevalence of <italic>gr/gr</italic> and <italic>b2/b3</italic> partial <italic>AZFc</italic> deletions is variable across populations and Y-chromosomal lineages, from fixed events on some Y-lineages to no known deletions on other lineages.</p><p>A total of 410 Y-chromosomal deletions are included in the gnomAD (v2.1) database, ranging in size from 51 bp to only two longer than 1 Mb (1.07 Mb and 3.6 Mb). Neither of these two &gt;1 Mb-long deletions match the size and/or location of well-established <italic>gr/gr</italic> and <italic>b2/b3</italic> deletions, although both of these are fixed in some Y-lineages. Also, in the current gnomAD SV database, no Y-chromosomal inversions have been mapped.</p><p>Based on the affected gene content, two duplication variants in the gnomAD SV database correspond well to complex structural variants included in the current manuscript: the <italic>b2/b4</italic> duplication following the <italic>gr/gr</italic> deletion (ID: DUP_Y_55084; 114 subjects in gnomAD; length 2,105,101 bp, gain of 2 <italic>DAZ</italic>, 2 <italic>BPY2</italic> and 1 <italic>CDY1</italic> genes) and the <italic>b2/b4</italic> duplication following the <italic>b2/b3</italic> deletion (ID: DUP_Y_55085; 58 subjects in gnomAD; length 1,589,100 bp, gain of 2 <italic>DAZ</italic>, 1 <italic>BPY2</italic> and 1 <italic>CDY1</italic> genes). We have added Supplementary file 8 with the frequency data of these variants in different populations and extended the text in the respective Results section.</p><p>A possible explanation of the limited representation of the <italic>AZFc</italic> structural variants in gnomAD:</p><p>The Y-chromosomal <italic>AZFc</italic> region is composed of six amplicon units with ≥99.94% nucleotide identity, repeated in direct and inverted orientations from two to four times (Figure 1B in the manuscript). The whole region nearly lacks unique genomic sequence and identifying SVs from short-read WGS data is challenging, requiring care and custom approaches that take into account the expected number of each amplicon unit according to human Y chromosome reference sequence (see Teitz et al. 2018). In general, the analytical tools developed for regions with mostly unique sequence do not perform well for the analysis of SVs in highly duplicated genomic regions undergoing constant gene conversion keeping their DNA sequences (nearly) identical.</p><p>As an example, when conventional short-read WGS data of the Y-chromosome with two (out of four) deleted <italic>DAZ</italic> gene copies is mapped to the reference sequence, it would appear that all four <italic>DAZ</italic> genes were still present but with slightly reduced read depth. There are very few unique sequence positions that differ between the highly homologous <italic>DAZ</italic> genes (and other segments in the <italic>AZFc</italic> region, see Figure 1B) and the conventional sequence alignment tools lack sensitivity for their detection.</p><p>However, with the careful custom approach taken in the current study that included, first, the determination of the gene copy numbers, and then re-sequencing of the retained genes and targeted genotyping of gene-specific paralogous sequence variants, it was possible to determine the exact present and lost gene copies.</p><disp-quote content-type="editor-comment"><p>Furthermore, an estimate of the r2/r3 inversion variant in both European and non-European populations would add important context and potential impact of the inversion+deletion risk allele. If any alleles are not represented in gnomAD SV the authors should comment as to why.</p></disp-quote><p>We have explained above why the <italic>r2/r3</italic> inversion variant is not present in gnomAD SV. In addition, we have shown that <italic>r2/r3</italic> inversion is most probably fixed in one specific European Y-chromosomal lineage. The frequency of this lineage in different European populations is provided in Supplementary file 15 and on Figure 4A, ranging from 0 in many populations to over 20% in some Central and Eastern European populations. The frequency data originate from Underhill et al., 2015, the most comprehensive investigation of the distribution of R1a-M420 sub-lineages to date, using a total of 16,244 male samples from 126 Eurasian populations and showing that R1a1-M458 is virtually absent outside of Europe.</p><disp-quote content-type="editor-comment"><p>2) In general the primary genotyping data are underrepresented in the figures and supplement. For example, a histogram depicting estimated copy number from the ddPCR experiments would be useful. Good separation of the signal distributions centered around biologically interpretable copy numbers would indicate that the assay is well calibrated with minimal genotyping errors.</p></disp-quote><p>We thank the reviewer for the comment and have now included a new Figure 2—figure supplement 1 showing the distribution of raw estimated <italic>DAZ</italic>, <italic>BPY2</italic> and <italic>CDY</italic> copy numbers using droplet digital PCR. Figure 2—figure supplement 1 shows that the raw estimates correspond well to biologically interpretable copy numbers except for some uncertainty among the highest numbers.</p><disp-quote content-type="editor-comment"><p>3) Are histopathology data from testis biopsies (e.g., see https://doi.org/10.1056/NEJMoa1406192) for cases with the risk allele available? This material may already be banked as part of the infertility workup. If so reporting of these results would be welcomed to help support the model of meiotic failure over gene dosage changes. If not, please mention this as a follow-up opportunity in your Discussion.</p></disp-quote><p>In infertility clinics, testis biopsy is mostly used for men with azoospermia. The intention of this invasive procedure is to possibly detect and retrieve immature sperms (through the TESE procedure) that can be used for ICSI to achieve the fertilization of the partner’s oocyte. Among the Estonian patients carrying <italic>r2/r3</italic> inversion plus deletion, there was only one azoospermia patient, but he had not undergone testicular biopsy. Our Discussion has been extended to include this limitation, stressing the importance of testicular histopathological phenotype assessment in future studies to understand the consequences of this rearrangement for spermatogenesis and to maximize the benefit of molecular diagnostics.</p><disp-quote content-type="editor-comment"><p>4) Please also discuss the potential future benefit (unless these data can be readily generated now) of long-read sequencing (e.g., ONT, PacBio) data to help resolve the relative orientations of the amplicons in one of their inversion+deletion patients. (A traditional cytogenetics approach (i.e., FISH with multiple colored probes) would also work but would require additional biological material). In particular, the long-read sequencing based approach has the added benefit of nominating a putative inversion breakpoint that could be fine-mapped and validated. The authors infer that the r2/r3 inversion is a single, fixed lineage-specific event, but breakpoint information in multiple individuals would much more rigorously rule out a recurrent rearrangement scenario.</p></disp-quote><p>We have extended the Discussion by adding such future actions to resolve the detailed structure of R1a1-M458 chromosomes and the breakpoints of <italic>r2/r3</italic> inversion and secondary deletions using long-read sequencing.</p><p>In regards to whether the <italic>r2/r3</italic> inversion is fixed or represents a recurrent event in the R1a1-M458 and its sub-lineages, we agree that formally the scenario of recurrent events cannot be rejected. However, with the available phylogenetic information, the possibility of recurrent inversion events is highly unlikely as the Y chromosomes of all the samples with the proposed inversion are closely related and descendants of a single, R1a1-M458 lineage. In support to the lineage-specific fixed event, the <italic>r2/3</italic> inversion was not identified in any other Y-chromosomal lineages in our large sample set.</p><p>The low probability of recurrent inversions in R1a1-M458 and its sub-lineages is supported by the split times of these Y chromosomes and estimated mutation rate for Y-chromosomal inversions. It is not possible to estimate the split times of the analysed Y chromosomes and using the data generated in this study; however, we can take advantage of publicly available whole-genome sequenced samples belonging to the same Y-chromosomal lineages (R1a1-M458 and its sub-lineages). The recently published analysis of the whole-genome sequenced Human Genome Diversity Project (HGDP) panel contains 5 males carrying sub-lineages of R1a1-M458 (Bergström et al. 2020, doi:10.1126/science.aay5012), with the time to most recent common ancestor (TMRCA) estimated at approximately 5,000 years.</p><p>Unfortunately, no estimated inversion rate is available for the <italic>AZFc</italic> region, but a mutation rate of approximately 2.3 x 10<sup>-4</sup> events per father-to-son Y transmission has been estimated for recurrent Y-chromosomal IR3/IR3 inversions and can perhaps be used as a rough proxy (Repping et al. 2006; doi:10.1038/ng1754). This rate translates to roughly 1 inversion per 4,347 generations, or using a 30-year male generation time, approx. 1 event per 130,434 years.</p><p>Therefore, even if the inversion rate in the <italic>AZFc</italic> region is substantially higher than that estimated for the IR3/IR3 repeats, the occurrence of multiple inversions among Y chromosomes with such a recent TMRCA seems highly unlikely.</p><disp-quote content-type="editor-comment"><p>5) Also with respect to the request for slightly expanded Discussion, please offer some comments on potential approaches for (and or challenges associated with) replicating this result in another population/sample.</p></disp-quote><p>We have extended the Discussion section to suggest replication of the results in other populations, and the possible challenges associated with it.</p><disp-quote content-type="editor-comment"><p>6) In the Results, please provide more explicit links to the specific assays/methods used to generate them, to aid reader understanding. For example, providing a short phrase that ddPCR (with a half-sentence description of the method) was used to quantify the DAZ, BPY2, and CDY genes. This information is laid out in the Materials and methods but adding to the Results will make the paper more readable.</p></disp-quote><p>The Results sections were extended to include such statements about the specific assays and methods used.</p><disp-quote content-type="editor-comment"><p>In addition, while the complexity and existing nomenclature of the AZF region contribute to the density of information in the Results section, as you identify descriptive wording that could be trimmed/compressed for readability, please make such changes.</p></disp-quote><p>We have modified the Results and Discussion sections when talking about the <italic>r2/r3</italic> inversion followed by secondary deletions as “<italic>r2/r3</italic> inversion plus deletion” for smoother readability.</p><disp-quote content-type="editor-comment"><p>7) Are the Pairwise Wilcoxon Rank Sum Test P-values in Figure 3 and Supplementary file 3 corrected for multiple tests? It's stated that the linear regression for Supplementary file 4 accounts for multiple tests only. Some P-values values in Supplementary file 3 are in bold but unless I'm missing it, it's not stated why.</p></disp-quote><p>The Pairwise Wilcoxon Rank Sum Test <italic>p</italic>-values presented in Figure 3 and Supplementary file 3 were not corrected for multiple tests. To make this obvious to the reader, we have now included the following sentence in the figure and table legends, stating the statistical significance threshold after correcting for multiple testing: &quot;Statistical significance threshold after correction for multiple testing was estimated <italic>P</italic>&lt;1.0 x 10<sup>-3</sup> (a total of 5 tests x 10 independent parameters)&quot;. We have also added an explanation to Supplementary file 3 about <italic>p</italic>-values shown in bold. Further, in the Results section “<italic>r2/r3</italic> inversion promotes recurrent…” it is now explicitly said that the reported test result reflects a nominal <italic>p</italic>-value.</p></body></sub-article></article>